84 results on '"C Michael Cawley"'
Search Results
2. Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Predictors of Clinical and Radiographic Failure from 636 Embolizations
- Author
-
Mohamed M. Salem, Okkes Kuybu, Alex Nguyen Hoang, Ammad A. Baig, Mirhojjat Khorasanizadeh, Cordell Baker, Joshua C. Hunsaker, Aldo A. Mendez, Gustavo Cortez, Jason M. Davies, Sandra Narayanan, C. Michael Cawley, Howard A. Riina, Justin M. Moore, Alejandro M. Spiotta, Alexander A. Khalessi, Brian M. Howard, Ricardo Hanel, Omar Tanweer, Elad I. Levy, Ramesh Grandhi, Michael J. Lang, Adnan H. Siddiqui, Peter Kan, Christopher S. Ogilvy, Bradley A. Gross, Ajith J. Thomas, Brian T. Jankowitz, and Jan-Karl Burkhardt
- Subjects
Radiology, Nuclear Medicine and imaging - Published
- 2023
3. Prospective study on embolization of intracranial aneurysms with the pipeline device (PREMIER study): 3-year results with the application of a flow diverter specific occlusion classification
- Author
-
Ricardo A Hanel, Gustavo M Cortez, Demetrius Klee Lopes, Peter Kim Nelson, Adnan H Siddiqui, Pascal Jabbour, Vitor Mendes Pereira, Istvan Szikora István, Osama O Zaidat, Chetan Bettegowda, Geoffrey P Colby, Maxim Mokin, Clemens M Schirmer, Frank R Hellinger, Curtis Given, Timo Krings, Philipp Taussky, Gabor Toth, Justin F Fraser, Michael Chen, Ryan Priest, Peter Kan, David Fiorella, Donald Frei, Beverly Aagaard-Kienitz, Orlando Diaz, Adel M Malek, C Michael Cawley, Ajit S Puri, and David F Kallmes
- Subjects
Clinical Trials and Supportive Activities ,Neurosciences ,flow diverter ,Intracranial Aneurysm ,Hematology ,General Medicine ,Cerebral Angiography ,Stroke ,Embolization ,Treatment Outcome ,Clinical Research ,aneurysm ,Humans ,Surgery ,Prospective Studies ,Neurology (clinical) ,Therapeutic ,intervention ,Retrospective Studies ,Follow-Up Studies - Abstract
BackgroundThe pipeline embolization device (PED; Medtronic) has presented as a safe and efficacious treatment for small- and medium-sized intracranial aneurysms. Independently adjudicated long-term results of the device in treating these lesions are still indeterminate. We present 3-year results, with additional application of a flow diverter specific occlusion scale.MethodsPREMIER (prospective study on embolization of intracranial aneurysms with pipeline embolization device) is a prospective, single-arm trial. Inclusion criteria were patients with unruptured wide-necked intracranial aneurysms ≤12 mm. Primary effectiveness (complete aneurysm occlusion) and safety (major neurologic event) endpoints were independently monitored and adjudicated.ResultsAs per the protocol, of 141 patients treated with a PED, 25 (17.7%) required angiographic follow-up after the first year due to incomplete aneurysm occlusion. According to the Core Radiology Laboratory review, three (12%) of these patients progressed to complete occlusion, with an overall rate of complete aneurysm occlusion at 3 years of 83.3% (115/138). Further angiographic evaluation using the modified Cekirge–Saatci classification demonstrated that complete occlusion, neck residual, or aneurysm size reduction occurred in 97.1%. The overall combined safety endpoint at 3 years was 2.8% (4/141), with only one non-debilitating major event occurring after the first year. There was one case of aneurysm recurrence but no cases of delayed rupture in this series.ConclusionsThe PED device presents as a safe and effective modality in treating small- and medium-sized intracranial aneurysms. The application of a flow diverter specific occlusion classification attested the long-term durability with higher rate of successful aneurysm occlusion and no documented aneurysm rupture.Trial registrationNCT02186561.
- Published
- 2022
4. Diffuse Angiogram-Negative Subarachnoid Hemorrhage is Associated with an Intermediate Clinical Course
- Author
-
Feras Akbik, Cederic Pimentel-Farias, Di’Jonai A. Press, Niara E. Foster, Kevin Luu, Merin G. Williams, Sena G. Andea, Regina K. Kyei, Grace M. Wetsel, Jonathan A. Grossberg, Brian M. Howard, Frank Tong, C. Michael Cawley, Owen B. Samuels, and Ofer Sadan
- Subjects
Neurology (clinical) ,Critical Care and Intensive Care Medicine - Published
- 2021
5. Technical and clinical outcomes in concurrent multivessel occlusions treated with mechanical thrombectomy: insights from the STAR collaboration
- Author
-
Hassan Saad, Sheila Eshraghi, Ali M Alawieh, Feras Akbik, C Michael Cawley, Brian M Howard, Makenna Ash, Alice Hsu, Aqueel Pabaney, Ilko Maier, Sami Al Kasab, Kareem El Naamani, Pascal Jabbour, Joon-tae Kim, Stacey Q Wolfe, Ansaar Rai, Robert M Starke, Marios-Nikos Psychogios, Amir Shaban, Adam S Arthur, Shinichi Yoshimura, Isabel Fragata, Hugo H Cuellar-Saenz, Adam J Polifka, Justin Mascitelli, Joshua W Osbun, Charles Matouk, Min S Park, Michael R Levitt, Travis M Dumont, Richard Williamson, Alejandro M Spiotta, and Jonathan A Grossberg
- Subjects
Surgery ,Neurology (clinical) ,General Medicine - Abstract
BackgroundEndovascular thrombectomy (EVT) has become the mainstay treatment for large vessel occlusion, with favorable safety and efficacy profile. However, the safety and efficacy of EVT in concurrent multi-territory occlusions (MTVOs) remains unclear.ObjectiveTo investigate the prevalence, clinical and technical outcomes of concurrent EVT for MTVOs.MethodsData were included from the Stroke Thrombectomy and Aneurysm Registry (STAR) with 32 stroke centers for EVT performed to treat bilateral anterior or concurrent anterior and posterior circulation occlusions between 2017 and 2021. Patients with MTVO were identified, and propensity score matching was used to compare this group with patients with occlusion in a single arterial territory.ResultsOf a total of 7723 patients who underwent EVT for acute ischemic stroke, 54 (0.7%) underwent EVT for MTVOs (mean age 69±12.5; female 50%). 28% had bilateral and 72% had anterior and posterior circulations occlusions. The rate of successful recanalization (Thrombolysis in Cerebral Infarction 2b/3), complications, modified Rankin score at 90 days, and mortality was not significantly different between the matched cohorts. Multivariate analysis confirmed that MTVOs were not associated with poor functional outcome, symptomatic intracranial hemorrhage, or longer procedure time.ConclusionCompared with EVT for single vessel occlusions, EVT in appropriately selected patients with MTVOs has a similar efficacy and safety profile.
- Published
- 2022
6. Cannabis Use Is Not Associated With Aneurysmal Subarachnoid Hemorrhage Complications or Outcomes
- Author
-
Feras Akbik, Heather-Destiny Konan, Kayla P. Williams, Leelt M. Ermias, Yuyang Shi, Obai Takieddin, Jonathan A. Grossberg, Brian M. Howard, Frank Tong, C. Michael Cawley, Yajun Mei, Owen B. Samuels, and Ofer Sadan
- Subjects
Advanced and Specialized Nursing ,Humans ,Intracranial Aneurysm ,Neurology (clinical) ,Subarachnoid Hemorrhage ,Cardiology and Cardiovascular Medicine ,Cannabis - Published
- 2022
7. Aneurysmal recurrence after successful flow-diversion embolization
- Author
-
Feras Akbik, Hassan Saad, Jonathan A Grossberg, Frank C Tong, C Michael Cawley, and Brian M Howard
- Abstract
Aneurysmal recurrence after successful flow-diversion embolization is exceptionally rare. The rarity of recurrence has called into question the yield of interval surveillance imaging. Here we report the case of a recurrent intracranial aneurysm despite complete angiographic resolution after flow-diversion therapy with a Pipeline embolization device (PED). Given the absence of poor wall apposition, endoleak, and device migration, how this aneurysm recurred remains unclear, particularly given the recurrence was at a timepoint at which complete reendothelialization of the device would be expected. The patient ultimately underwent interval treatment with a second device placed across the neck of the aneurysm. Although rare, reports of aneurysmal recurrences support the use of interval non-invasive imaging surveillance to ensure successful embolization in this patient population.
- Published
- 2022
8. Multicenter investigation of technical and clinical outcomes after thrombectomy for distal vessel occlusion by frontline technique
- Author
-
Ali M Alawieh, Reda M Chalhoub, Sami Al Kasab, Pascal Jabbour, Marios-Nikos Psychogios, Robert M Starke, Adam S Arthur, Kyle M Fargen, Reade De Leacy, Peter Kan, Travis M Dumont, Ansaar Rai, Roberto Javier Crosa, Ilko Maier, Nitin Goyal, Stacey Q Wolfe, C Michael Cawley, J Mocco, Stavropoula I Tjoumakaris, Brian M Howard, Laurie Dimisko, Hassan Saad, Christopher S Ogilvy, R Webster Crowley, Justin R Mascitelli, Isabel Fragata, Michael R Levitt, Joon-tae Kim, Min S Park, Benjamin Gory, Adam J Polifka, Charles Matouk, Jonathan A Grossberg, and Alejandro M Spiotta
- Subjects
Surgery ,Neurology (clinical) ,General Medicine - Abstract
BackgroundEndovascular thrombectomy (EVT) is the standard-of-care for proximal large vessel occlusion (LVO) stroke. Data on technical and clinical outcomes in distal vessel occlusions (DVOs) remain limited.MethodsThis was a retrospective study of patients undergoing EVT for stroke at 32 international centers. Patients were divided into LVOs (internal carotid artery/M1/vertebrobasilar), medium vessel occlusions (M2/A1/P1) and isolated DVOs (M3/M4/A2/A3/P2/P3) and categorized by thrombectomy technique. Primary outcome was a good functional outcome (modified Rankin Scale ≤2) at 90 days. Secondary outcomes included recanalization, procedure-time, thrombectomy attempts, hemorrhage, and mortality. Multivariate logistic regressions were used to evaluate the impact of technical variables. Propensity score matching was used to compare outcome in patients with DVO treated with aspiration versus stent retrieverResultsWe included 7477 patients including 213 DVOs. Distal location did not independently predict good functional outcome at 90 days compared with proximal (p=0.467). In distal occlusions, successful recanalization was an independent predictor of good outcome (adjusted odds ratio (aOR) 5.11, pConclusionsOutcomes following EVT for DVO are comparable to LVO with similar results between techniques. Techniques may exhibit different futility metrics; stent retriever thrombectomy was influenced by attempts whereas aspiration was more dependent on procedure time.
- Published
- 2022
9. Middle meningeal artery embolization as a perioperative adjunct to surgical evacuation of nonacute subdural hematomas: An multicenter analysis of safety and efficacy
- Author
-
Walid K. Salah, Cordell Baker, Jonathan P. Scoville, Joshua C. Hunsaker, Christopher S. Ogilvy, Justin M. Moore, Howard A. Riina, Elad I. Levy, Alejandro M. Spiotta, Brian T. Jankowitz, C. Michael Cawley, Alexander A. Khalessi, Omar Tanweer, Ricardo Hanel, Bradley A. Gross, Okkes Kuybu, Alex Nguyen Hoang, Ammad A. Baig, Mir Hojjat Khorasanizadeh, Aldo A. Mendez, Gustavo Cortez, Jason M. Davies, Sandra Narayanan, Brian M. Howard, Michael J. Lang, Adnan H. Siddiqui, Ajith Thomas, Peter Kan, Jan-Karl Burkhardt, Mohamed M. Salem, and Ramesh Grandhi
- Subjects
General Medicine - Abstract
Background By 2030, nonacute subdural hematomas (NASHs) will likely be the most common cranial neurosurgery pathology. Treatment with surgical evacuation may be necessary, but the recurrence rate after surgery is as high as 30%. Minimally invasive middle meningeal artery embolization (MMAE) during the perioperative period has been posited as an adjunctive treatment to decrease the potential for recurrence after surgical evacuation. We evaluated the safety and efficacy of concurrent MMAE in a multi-institutional cohort. Methods Data from 145 patients (median age 73 years) with NASH who underwent surgical evacuation and MMAE in the perioperative period were retrospectively collected from 15 institutions. The primary outcome was the rate of recurrence requiring repeat surgical intervention. We collected clinical, treatment, and radiographic data at initial presentation, after evacuation, and at 90-day follow-up. Outcomes data were also collected. Results Preoperatively, the median hematoma width was 18 mm, and subdural membranes were present on imaging in 87.3% of patients. At 90-day follow-up, median NASH width was 6 mm, and 51.4% of patients had at least a 50% decrease of NASH size on imaging. Eight percent of treated NASHs had recurrence that required additional surgical intervention. Of patients with a modified Rankin Scale score at last follow-up, 87.2% had the same or improved mRS score. The total all-cause mortality was 6.0%. Conclusion This study provides evidence from a multi-institutional cohort that performing MMAE in the perioperative period as an adjunct to surgical evacuation is a safe and effective means to reduce recurrence in patients with NASHs.
- Published
- 2023
10. Combined Microsurgical and Endovascular Treatment of Cerebrovascular and Skull Base Pathology
- Author
-
Brian M. Howard, Daniel L. Barrow, Jonathan A Grossberg, and C. Michael Cawley
- Subjects
medicine.medical_specialty ,Skull ,medicine.anatomical_structure ,business.industry ,Medicine ,Endovascular treatment ,business ,Base (exponentiation) ,Surgery - Published
- 2021
11. Multicenter investigation of technical and clinical outcomes after thrombectomy for Proximal Medium Vessel Occlusion (pMeVO) by frontline technique
- Author
-
Jonathan A Grossberg, Reda M Chalhoub, Sami Al Kasab, Dominika Pullmann, Pascal Jabbour, Marios Psychogios, Robert M Starke, Adam S Arthur, Kyle M Fargen, Reade De Leacy, Peter Kan, Travis Dumont, Ansaar Rai, Roberto J Crosa, Kareem E Naamani, Ilko Maier, Nitin Goyal, Stacey Quintero Wolfe, C Michael Cawley, J Mocco, Muhammad Hafeez, Brian M Howard, Laurie Dimisko, Hassan Saad, Christopher S Ogilvy, R Webster Crowley, Justin Mascitelli, Isabel Fragata, Michael Levitt, Alejandro M Spiotta, and Ali M Alawieh
- Subjects
General Medicine - Abstract
Background Endovascular thrombectomy(EVT) is the standard of care for large vessel occlusion(LVO) stroke. Data on technical and clinical outcome in proximal medium vessel occlusions(pMeVOs) comparing frontline techniques remain limited. Methods We report an international multicenter retrospective study of patients undergoing EVT for stroke at 32 centers between 2015–2021. Patients were divided into LVOs(ICA/M1/Vertebrobasilar) or pMeVOs(M2/A1/P1) and categorized by thrombectomy technique. Primary outcome was 90-day good functional outcome(mRS ≤ 2). Multivariate logistic regressions were used to evaluate the impact of technical variables on clinical outcomes. Propensity score matching was used to compare outcome in patients with pMeVO treated with aspiration versus stent-retriever. Results In the cohort of 5977 LVO and 1287 pMeVO patients, pMeVO did not independently predict good-outcome(p = 0.55). In pMeVO patients, successful recanalization irrespective of frontline technique(aOR = 3.2,p Conclusions Clinical outcomes following EVT for pMeVO are comparable to those in LVOs. The golden hour or 3-pass rules in LVO thrombectomy still apply to pMeVO thrombectomy. Different techniques may exhibit different futility metrics; SR thrombectomy was more influenced by attempts whereas aspiration was more dependent on procedure time.
- Published
- 2022
12. Diffuse Angiogram-Negative Subarachnoid Hemorrhage is Associated with an Intermediate Clinical Course
- Author
-
Feras, Akbik, Cederic, Pimentel-Farias, Di'Jonai A, Press, Niara E, Foster, Kevin, Luu, Merin G, Williams, Sena G, Andea, Regina K, Kyei, Grace M, Wetsel, Jonathan A, Grossberg, Brian M, Howard, Frank, Tong, C Michael, Cawley, Owen B, Samuels, and Ofer, Sadan
- Subjects
Male ,Aftercare ,Humans ,Female ,Subarachnoid Hemorrhage ,Patient Discharge ,Cerebral Angiography ,Retrospective Studies - Abstract
The cerebral angiography result is negative for an underlying vascular lesion in 15-20% of patients with nontraumatic subarachnoid hemorrhage (SAH). Patients with angiogram-negative SAH include those with perimesencephalic SAH and diffuse SAH. Consensus suggests that perimesencephalic SAH confers a more favorable prognosis than diffuse SAH. Limited data exist to contextualize the clinical course and prognosis of diffuse SAH in relation to aneurysmal SAH in terms of critical care complications, neurologic complications, and functional outcomes. Here we compare the clinical course and functional outcomes of patients with perimesencephalic SAH, diffuse SAH, and aneurysmal SAH to better characterize the prognostic implications of each SAH subtype.We conducted a retrospective cohort study that included all patients with nontraumatic SAH admitted to a tertiary care referral center between January 1, 2012, and December 31, 2017. Bleed patterns were radiographically adjudicated, and patients were assigned to three groups: perimesencephalic SAH, diffuse SAH, and aneurysmal SAH. Patient demographics, complications, and clinical outcomes were reported and compared.Eighty-six patients with perimesencephalic SAH, 174 with diffuse SAH, and 998 with aneurysmal SAH presented during the study period. Patients with aneurysmal SAH were significantly more likely to be female, White, and active smokers. There were no significant differences between patients with diffuse SAH and perimesencephalic SAH patterns. Critical care complications were compared across all three groups, with significant between-group differences in hypotension and shock (3.5% vs. 16.1% vs. 38.4% for perimesencephalic SAH vs. diffuse SAH vs. aneurysmal SAH, respectively; p 0.01) and endotracheal intubation (0% vs. 26.4% vs. 48.8% for perimesencephalic SAH vs. diffuse SAH vs. aneurysmal SAH, respectively; p 0.01). Similar trends were noted with long-term supportive care with tracheostomy and gastrostomy tubes and length of stay. Cerebrospinal fluid diversion was increasingly required across bleed types (9.3% vs. 54.6% vs. 76.3% for perimesencephalic SAH vs. diffuse SAH vs. aneurysmal SAH, respectively, p 0.001). Vasospasm and delayed cerebral ischemia were comparable between perimesencephalic SAH and diffuse SAH but significantly lower than aneurysmal SAH. Patients with diffuse SAH had intermediate functional outcomes, with significant rates of nonhome discharge (23.0%) and poor functional status on discharge (26.4%), significantly higher than patients with perimesencephalic SAH and lower than patients with aneurysmal SAH. Diffuse SAH similarly conferred an intermediate rate of good functional outcomes at 1-6 months post discharge (92.3% vs. 78.6% vs. 47.3% for perimesencephalic SAH vs. diffuse SAH vs. aneurysmal SAH, respectively; p 0.016).We confirm the consensus data that perimesencephalic SAH is associated with a more benign clinical course but demonstrate that diffuse SAH confers an intermediate prognosis, more malignant than perimesencephalic SAH but not as morbid as aneurysmal SAH. These results highlight the significant morbidity associated with diffuse SAH and emphasize need for vigilance in the acute care of these patients. These patients will likely benefit from continued high-acuity observation and potential support to avert significant risk of morbidity and neurologic compromise.
- Published
- 2021
13. Bridging thrombolysis in atrial fibrillation stroke is associated with increased hemorrhagic complications without improved outcomes
- Author
-
J Mocco, Frank C. Tong, Marios Psychogios, Travis M. Dumont, Feras Akbik, Stroke Thrombectomy, Peter Kan, Roberto Crosa, Adam S Arthur, Jan Liman, C. Michael Cawley, Wuwei Feng, Fadi Nahab, Ansaar T Rai, Pascal Jabbour, Jonathan A Grossberg, W. Christopher Fox, Ilko Maier, Saleh G. Keyrouz, Benjamin Gory, Reade De Leacy, Laurie Dimisko, Brian M. Howard, Owen Samuels, Alejandro M Spiotta, Stacey Q Wolfe, Nitin Goyal, Kyle M Fargen, Ali Alawieh, and Robert M. Starke
- Subjects
medicine.medical_specialty ,Mechanical Thrombolysis ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,Brain Ischemia ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Hematoma ,Fibrinolytic Agents ,Internal medicine ,Atrial Fibrillation ,Medicine ,Humans ,In patient ,Thrombolytic Therapy ,Prospective Studies ,Stroke ,Thrombectomy ,business.industry ,Atrial fibrillation ,General Medicine ,Thrombolysis ,medicine.disease ,3. Good health ,Treatment Outcome ,Hemorrhagic complication ,Propensity score matching ,Cardiology ,Surgery ,Neurology (clinical) ,business ,030217 neurology & neurosurgery ,Cohort study - Abstract
BackgroundAtrial fibrillation (AF) associated ischemic stroke is associated with worse functional outcomes, less effective recanalization, and increased rates of hemorrhagic complications after intravenous thrombolysis (IVT). Conversely, AF is not associated with hemorrhagic complications or functional outcomes in patients undergoing mechanical thrombectomy (MT). This differential effect of MT and IVT in AF associated stroke raises the question of whether bridging thrombolysis increases hemorrhagic complications in AF patients undergoing MT.MethodsThis international cohort study of 22 comprehensive stroke centers analyzed patients with large vessel occlusion (LVO) undergoing MT between June 1, 2015 and December 31, 2020. Patients were divided into four groups based on comorbid AF and IVT exposure. Baseline patient characteristics, complications, and outcomes were reported and compared.Results6461 patients underwent MT for LVO. 2311 (35.8%) patients had comorbid AF. In non-AF patients, bridging therapy improved the odds of good 90 day functional outcomes (adjusted OR (aOR) 1.29, 95% CI 1.03 to 1.60, p=0.025) and did not increase hemorrhagic complications. In AF patients, bridging therapy led to significant increases in symptomatic intracranial hemorrhage and parenchymal hematoma type 2 (aOR 1.66, 1.07 to 2.57, p=0.024) without any benefit in 90 day functional outcomes. Similar findings were noted in a separate propensity score analysis.ConclusionIn this large thrombectomy registry, AF patients exposed to IVT before MT had increased hemorrhagic complications without improved functional outcomes, in contrast with non-AF patients. Prospective trials are warranted to assess whether AF patients represent a subgroup of LVO patients who may benefit from a direct to thrombectomy approach at thrombectomy capable centers.
- Published
- 2021
14. Delayed Presentations and Worse Outcomes After Aneurysmal Subarachnoid Hemorrhage in the Early COVID-19 Era
- Author
-
Feras Akbik, Chris Yang, Brian M. Howard, Jonathan A. Grossberg, Lisa Danyluk, Kathleen S. Martin, Ali Alawieh, Rima S. Rindler, Frank C. Tong, Daniel L. Barrow, C. Michael Cawley, Owen B. Samuels, and Ofer Sadan
- Subjects
COVID-19 ,Humans ,Surgery ,Neurology (clinical) ,Subarachnoid Hemorrhage ,Pandemics ,Brain Ischemia ,Retrospective Studies - Abstract
The early phase of the COVID-19 pandemic led to significant healthcare avoidance, perhaps explaining some of the excess reported deaths that exceeded known infections. The impact of the early COVID-19 era on aneurysmal subarachnoid hemorrhage (aSAH) care remains unclear.To determine the impact of the early phase of the COVID-19 pandemic on latency to presentation, neurological complications, and clinical outcomes after aSAH.We performed a retrospective cohort study from March 2, 2012, to June 30, 2021, of all patients with aSAH admitted to our center. The early COVID-19 era was defined as March 2, 2020, through June 30, 2020. The pre-COVID-19 era was defined as the same interval in 2012 to 2019.Among 499 patients with aSAH, 37 presented in the early COVID-19 era. Compared with the pre-COVID-19 era patients, patients presenting during this early phase of the pandemic were more likely to delay presentation after ictus (median, interquartile range; 1 [0-4] vs 0 [0-1] days, respectively, P.001). Radiographic-delayed cerebral ischemia (29.7% vs 10.2%, P.001) was more common in the early COVID-19 era. In adjusted analyses, presentation in the early COVID-19 era was independently associated with increased inhospital death or hospice disposition (adjusted odds ratio 3.29 [1.02-10.65], P = .046). Both latency and adverse outcomes returned to baseline in 2021.aSAH in the early COVID-19 era was associated with delayed presentation, neurological complications, and worse outcomes at our center. These data highlight how healthcare avoidance may have increased morbidity and mortality in non-COVID-19-related neurosurgical disease.
- Published
- 2021
15. Prospective study on embolization of intracranial aneurysms with the pipeline device: the PREMIER study 1 year results
- Author
-
Adel M. Malek, C. Michael Cawley, Clemens M. Schirmer, Orlando M. Diaz, David Fiorella, Don Frei, Frank R Hellinger, Pascal Jabbour, Adnan H. Siddiqui, Michael Chen, Istvan Szikora István, David F. Kallmes, Peter Kim Nelson, Peter Kan, Timo Krings, Curtis A. Given, Philipp Taussky, Osama O. Zaidat, Maxim Mokin, Geoffrey P. Colby, Justin F. Fraser, Gábor Tóth, Demetrius K. Lopes, Beverly Aagaard-Kienitz, Ricardo A. Hanel, Ajit S. Puri, Ryan Priest, Chetan Bettegowda, and Vitor Mendes Pereira
- Subjects
Male ,medicine.medical_treatment ,Cardiovascular ,Occlusion ,Prospective Studies ,Embolization ,Stroke ,intervention ,flow diverter ,artery ,Hematology ,General Medicine ,Middle Aged ,Embolization, Therapeutic ,Hemorrhagic Stroke ,Treatment Outcome ,Retreatment ,Female ,Therapeutic ,Internal carotid artery ,Adult ,medicine.medical_specialty ,brain ,Vertebral artery ,Clinical Trials and Supportive Activities ,Self Expandable Metallic Stents ,Aneurysm ,Clinical Research ,Blood vessel prosthesis ,medicine.artery ,medicine ,Humans ,Aged ,business.industry ,Neurosciences ,Intracranial Aneurysm ,medicine.disease ,Blood Vessel Prosthesis ,Surgery ,Stenosis ,aneurysm ,Neurology (clinical) ,business ,Follow-Up Studies - Abstract
BackgroundPreliminary clinical studies on the safety and efficacy of the pipeline embolization device (PED) for the treatment of small/medium aneurysms have demonstrated high occlusion rates with low complications.ObjectiveTo evaluate the safety and effectiveness of the PED for treatment of wide necked small and medium intracranial aneurysms.MethodsPREMIER is a prospective, multicenter, single arm trial. Patients were treated with the PED for unruptured wide necked aneurysms, measuring ≤12 mm along the internal carotid artery or vertebral artery, between July 2014 and November 2015. At 1 year post-procedure, the primary effectiveness endpoint was complete occlusion (Raymond grade 1) without major parent vessel stenosis (≤50%) or retreatment, and the primary safety endpoint was major stroke in the territory supplied by the treated artery or neurologic death.ResultsA total of 141 patients were treated with PEDs (mean age 54.6±11.3 years, 87.9% (124/141) women). Mean aneurysm size was 5.0±1.92 mm, and 84.4% (119/141) measured ConclusionsTreatment of wide necked small/medium aneurysms with the PED results in high rates of complete occlusion without significant parent vessel stenosis and low rates of permanent neurologic complications.Trial registrationNCT02186561.
- Published
- 2019
16. Pipeline Embolization of Vertebrobasilar Aneurysms—A Multicenter Case Series
- Author
-
Adam N. Wallace, C. Michael Cawley, Akash P. Kansagra, Thomas P Madaelil, Brian M. Howard, DeWitte T. Cross, Joshua W. Osbun, Matthew J Kole, Dheeraj Gandhi, Jacques E. Dion, Mudassar Kamran, Timothy R. Miller, Josser E Delgado Almandoz, Gaurav Jindal, Anil K. Roy, Jonathan A Grossberg, Yasha Kayan, Christopher J. Moran, and Travis S. CreveCoeur
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Vertebral artery ,Fusiform Aneurysm ,medicine.disease ,Surgery ,03 medical and health sciences ,Pseudoaneurysm ,0302 clinical medicine ,Aneurysm ,030220 oncology & carcinogenesis ,medicine.artery ,Occlusion ,cardiovascular system ,medicine ,Basilar artery ,cardiovascular diseases ,Neurology (clinical) ,Embolization ,business ,Stroke ,030217 neurology & neurosurgery - Abstract
Background The Pipeline Embolization Device (PED) has been increasingly used for the treatment of posterior circulation aneurysms. The purpose of the present study was to examine the clinical and angiographic outcomes of patients with vertebrobasilar aneurysms treated with the PED. Methods We performed a retrospective review of vertebrobasilar aneurysms treated with the PED at 4 high-volume neurovascular centers. Patient, aneurysm, and procedural data were collected, including perioperative and delayed complications. Aneurysm occlusion on follow-up imaging studies was defined as complete (100%), near-complete (>90%), or incomplete ( Results The cohort included 35 patients with 37 vertebrobasilar aneurysms who underwent 36 treatment sessions. Of the 35 patients, 10 were men (29%), and the mean patient age was 54.1 years (range, 32–75). Eight patients (23%) underwent urgent treatment because of a ruptured aneurysm (n = 6), brainstem perforator stroke (n = 1), or post-traumatic pseudoaneurysm (n = 1). Of the 37 aneurysms, 22 arose from the vertebral artery (59%) and 15 from the basilar artery (41%). Also, 19 were saccular aneurysms (51%), with a mean size of 7.7 mm (range, 1.7–38.0); 17 were fusiform aneurysms (46%), with a mean size of 11.0 mm (range, 4.3–34); and 1 was a 2.9-mm blister aneurysm. The overall procedural complication rate was 14% (5 of 36), including 3 neurologically symptomatic complications. At a mean follow-up period of 14 months (range, 3–59), 24 of 34 aneurysms (71%) were completely occluded and 29 of 34 (85%) were completely or near-completely occluded. Conclusion Our results show that Pipeline embolization of vertebrobasilar aneurysms is associated with acceptable occlusion and complication rates.
- Published
- 2019
17. Radiographic and clinical outcomes with particle or liquid embolic agents for middle meningeal artery embolization of nonacute subdural hematomas
- Author
-
Jonathan P. Scoville, Evan Joyce, Daniel A. Tonetti, Michael T. Bounajem, Ajith Thomas, Christopher S. Ogilvy, Justin M. Moore, Howard A. Riina, Omar Tanweer, Elad I. Levy, Alejandro M. Spiotta, Bradley A. Gross, Brian T. Jankowitz, C. Michael Cawley, Alexander A. Khalessi, Aditya S. Pandey, Andrew J. Ringer, Ricardo Hanel, Rafael A. Ortiz, David Langer, Michael R. Levitt, Mandy Binning, Philipp Taussky, Peter Kan, and Ramesh Grandhi
- Abstract
Background Middle meningeal artery (MMA) embolization is an apparently efficacious minimally invasive treatment for nonacute subdural hematomas (NASHs), but how different embolisates affect outcomes remains unclear. Our objective was to compare radiographic and clinical outcomes after particle or liquid MMA embolization. Methods Patients who had MMA embolization for NASH were retrospectively identified from a multi-institution database. The primary radiographic and clinical outcomes—50% NASH thickness reduction and need for surgical retreatment within 90 days, respectively—were compared for liquid and particle embolizations in patients treated 1) without surgical intervention (upfront), 2) after recurrence, or 3) with concomitant surgery (prophylactic). Results The upfront, recurrent, and prophylactic subgroups included 133, 59, and 16 patients, respectively. The primary radiographic outcome was observed in 61.8%, 61%, and 72.7% of particle-embolized patients and 61.3%, 55.6%, and 20% of liquid-embolized patients, respectively (p = 0.457, 0.819, 0.755). Hazard ratios comparing time to reach radiographic outcome in the particle and liquid groups or upfront, recurrent, andprophylactic timing were 1.31 (95% CI 0.78–2.18; p = 0.310), 1.09 (95% CI 0.52–2.27; p = 0.822), and 1.5 (95% CI 0.14–16.54; p = 0.74), respectively. The primary clinical outcome occurred in 8.0%, 2.4%, and 0% of patients who underwent particle embolization in the upfront, recurrent, and prophylactic groups, respectively, compared with 0%, 5.6%, and 0% who underwent liquid embolization (p = 0.197, 0.521, 1.00). Conclusions MMA embolization with particle and liquid embolisates appears to be equally effective in treatment of NASHs as determined by the percentage who reach, and the time to reach, 50% NASH thickness reduction and the incidence of surgical reintervention within 90 days.
- Published
- 2022
18. Pipeline embolization device treatment of internal carotid artery terminus aneurysms
- Author
-
Brian M. Howard, Anil K. Roy, Thomas P Madaelil, Susana L Skukalek, Jonathan A Grossberg, C. Michael Cawley, Amit Pujari, and Jacques E. Dion
- Subjects
Adult ,Carotid Artery Diseases ,Male ,medicine.medical_specialty ,Subarachnoid hemorrhage ,Patient demographics ,medicine.medical_treatment ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Maximum diameter ,Chart review ,medicine.artery ,Occlusion ,medicine ,Humans ,cardiovascular diseases ,Embolization ,Neck diameter ,Retrospective Studies ,business.industry ,Angiography, Digital Subtraction ,Intracranial Aneurysm ,Off-Label Use ,General Medicine ,Middle Aged ,medicine.disease ,Embolization, Therapeutic ,Blood Vessel Prosthesis ,Surgery ,Treatment Outcome ,cardiovascular system ,Female ,Neurology (clinical) ,Internal carotid artery ,business ,Carotid Artery, Internal ,030217 neurology & neurosurgery ,Follow-Up Studies - Abstract
BackgroundThe pipeline embolization device (PED) is approved for the treatment of large aneurysms of the proximal internal carotid artery (ICA). Its off-label application in treating aneurysms located specifically at the ICA terminus (ICA-T) has not been studied.MethodsWe conducted a retrospective chart review of patients from 2011 to 7 treated with PEDs. Out of 365 patients, 10 patients with ICA-T aneurysms were included. Patient demographics, procedural information, follow-up imaging, and clinical assessments were recorded.ResultsMean age was 46.9 years (± 8.8), and 6 (60%) patients were women. The mean maximum diameter of the aneurysms treated was 14.7 mm (± 10.7) and the mean neck diameter was 9.3 mm (± 6.6). Reasons for presentation included six incidental findings, one acute subarachnoid hemorrhage (SAH), and three patients with prior SAH. Kamran–Byrne Occlusion Scale scores for the treated aneurysms were as follows: three class IV (complete obliteration), four class III (ConclusionThe PED has potential for treating ICA-T aneurysms not amenable to conventional treatment strategies. Further studies are warranted to confirm the long term outcomes.
- Published
- 2018
19. Abstract P20: Bridging Therapy Increases Hemorrhagic Complications Without Improving Functional Outcomes in Atrial Fibrillation Associated Stroke
- Author
-
Marios Psychogios, Pascal Jabbour, Reade De Leacy, Ali Alawieh, Robert M. Starke, Ansaar T Rai, Adam S Arthur, Gustavo Pradilla, Alejandro M Spiotta, Peter Kan, Nitin Goyal, Feras Akbik, Laurie Dimisko, Brian M. Howard, Fadi Nahab, Jonathan A Grossberg, Ilko Maier, Hassan Saad, Frank C. Tong, Salah G. Keyrouz, Christian M. Mustroph, Roberto Crosa, Kyle M Fargen, Benjamin Gory, C. Michael Cawley, and Travis M. Dumont
- Subjects
Advanced and Specialized Nursing ,medicine.medical_specialty ,Bridging (networking) ,business.industry ,medicine.medical_treatment ,Atrial fibrillation ,Thrombolysis ,medicine.disease ,Endovascular therapy ,Aneurysm ,Internal medicine ,Hemorrhagic complication ,medicine ,Cardiology ,Neurology (clinical) ,Cardiology and Cardiovascular Medicine ,business ,Stroke - Abstract
* on behalf of the Stroke Thrombectomy and Aneurysm Registry (STAR) Collaborators Introduction: Intravenous thrombolysis complications are enriched in AF associated stroke, as these patients have worse functional outcomes, less effective recanalization, and increased rates of hemorrhagic complications. These data suggest that AF patients may be at particularly high risk for complications of bridging therapy for large vessel occlusions treated with mechanical thrombectomy (MT). Here we determine whether clinical outcomes differ in AF associated stroke treated with MT and bridging therapy. Methods: We performed a retrospective cohort study of the Stroke and Aneurysm Registry (STAR) from January 2015 to December 2018 and identified 4,169 patients who underwent MT for an anterior circulation stroke, 1,517 (36.4 %) of which had comorbid AF. Prospectively defined baseline characteristics and clinical outcomes were compared. Results: Hemorrhagic complications after MT were similar in patients with or without AF. In patients without AF, bridging therapy improved 90-day outcomes (aOR 1.32, 1.02-1.74, p Conclusions: Bridging therapy in AF patients undergoing thrombectomy independently increased the odds of intracranial hemorrhage and did not improve functional outcomes. AF patients may represent a high-risk subgroup for thrombolytic complications. Randomized trials are warranted to determine whether patients with AF associated stroke may benefit by deferring bridging therapy at thrombectomy-capable centers.
- Published
- 2021
20. Postmarket American Experience With Woven EndoBridge Device: Adjudicated Multicenter Case Series
- Author
-
Ramesh Grandhi, Jeremiah N. Johnson, Stephen R. Chen, Kunal Vakharia, Peter Kan, Frank C. Tong, Visish M Srinivasan, Bradley A. Gross, Matthew D Alexander, C. Michael Cawley, Elad I. Levy, Ajit S. Puri, Sheila R. Eshraghi, Brian M. Howard, Jan-Karl Burkhardt, and Jacob Cherian
- Subjects
Brain aneurysm ,medicine.medical_specialty ,Ruptured aneurysms ,Context (language use) ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Aneurysm ,Modified Rankin Scale ,Occlusion ,Medical imaging ,Medicine ,Humans ,Prospective Studies ,Prospective cohort study ,Retrospective Studies ,business.industry ,Endovascular Procedures ,Intracranial Aneurysm ,medicine.disease ,Embolization, Therapeutic ,United States ,Surgery ,Treatment Outcome ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
Background The Woven EndoBridge (WEB) device was granted premarket approval in the United States following results of the Woven EndoBridge Intrasaccular Therapy (WEB-IT) study. WEB-IT reported excellent adequate angiographic occlusion of treated aneurysms with a high safety profile. These results were achieved, however, in the context of a prospective study with strict inclusion criteria and rigorous training support. Objective To review early as-practiced clinical experience with the WEB device in the United States. Methods Retrospective review across 6 institutions identified 91 patients undergoing 92 treatment sessions for WEB device placement in treatment of 91 intracranial aneurysms. Details regarding demographics, aneurysm characteristics, treatment considerations, clinical outcomes, and aneurysm occlusion were obtained and analyzed in a multicenter database. Angiograms from the index procedure and follow-up studies were reviewed by a blinded and independent adjudicator. Results The middle cerebral, anterior communicating, and basilar artery complexes were the commonly treated locations. Eight patients presented with ruptured aneurysms. A mean of 1.2 devices were introduced per case. Technical failure without deployment of a WEB device occurred in 2% (2/92) of sessions. Adequate aneurysm occlusion for patients with imaging follow-up was 49% (mean follow-up of 8 mo). Four aneurysms were retreated. 90% of patients had modified Rankin Scale ≤ 2 at last clinical follow-up with no mortalities. Conclusion Immediate postmarket experience with the WEB device, newly introduced at American centers, confirms safe procedural use, but long-term efficacy remains unclear. Early challenges include accurate sizing and device selection.
- Published
- 2020
21. Does intrathecal nicardipine for cerebral vasospasm following subarachnoid hemorrhage correlate with reduced delayed cerebral ischemia? A retrospective propensity score-based analysis
- Author
-
Krista Garner, Lisa Danyluk, Ofer Sadan, Chen Feng, C. Michael Cawley, Feras Akbik, Alexis Taylor, Jennifer Kolenda, Subin Mathew, Jacqueline Kraft, Daniel L Barrow, Owen Samuels, William Asbury, Amit Pujari, Cederic Pimentel, R Loch Macdonald, Reneé H. Moore, Pouya Ameli, Hannah Waddel, David Pearce, Yajun Mei, Blessing N.R. Jaja, and Kathleen S Martin
- Subjects
Adult ,Male ,Subarachnoid hemorrhage ,Critical Care ,medicine.drug_class ,Aortic Rupture ,Nicardipine ,Calcium channel blocker ,Aneurysm, Ruptured ,Neurosurgical Procedures ,03 medical and health sciences ,0302 clinical medicine ,Cerebral vasospasm ,Modified Rankin Scale ,medicine ,Humans ,Vasospasm, Intracranial ,Propensity Score ,Injections, Spinal ,Aged ,Retrospective Studies ,business.industry ,Endovascular Procedures ,Age Factors ,Vasospasm ,General Medicine ,Odds ratio ,Middle Aged ,Subarachnoid Hemorrhage ,medicine.disease ,Calcium Channel Blockers ,Treatment Outcome ,030220 oncology & carcinogenesis ,Anesthesia ,Propensity score matching ,Female ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
OBJECTIVE Cerebral vasospasm and delayed cerebral ischemia (DCI) contribute to poor outcome following subarachnoid hemorrhage (SAH). With the paucity of effective treatments, the authors describe their experience with intrathecal (IT) nicardipine for this indication. METHODS Patients admitted to the Emory University Hospital neuroscience ICU between 2012 and 2017 with nontraumatic SAH, either aneurysmal or idiopathic, were included in the analysis. Using a propensity-score model, this patient cohort was compared to patients in the Subarachnoid Hemorrhage International Trialists (SAHIT) repository who did not receive IT nicardipine. The primary outcome was DCI. Secondary outcomes were long-term functional outcome and adverse events. RESULTS The analysis included 1351 patients, 422 of whom were diagnosed with cerebral vasospasm and treated with IT nicardipine. When compared with patients with no vasospasm (n = 859), the treated group was significantly younger (mean age 51.1 ± 12.4 years vs 56.7 ± 14.1 years, p < 0.001), had a higher World Federation of Neurosurgical Societies score and modified Fisher grade, and were more likely to undergo clipping of the ruptured aneurysm as compared to endovascular treatment (30.3% vs 11.3%, p < 0.001). Treatment with IT nicardipine decreased the daily mean transcranial Doppler velocities in 77.3% of the treated patients. When compared to patients not receiving IT nicardipine, treatment was not associated with an increased rate of bacterial ventriculitis (3.1% vs 2.7%, p > 0.1), yet higher rates of ventriculoperitoneal shunting were noted (19.9% vs 8.8%, p < 0.01). In a propensity score comparison to the SAHIT database, the odds ratio (OR) to develop DCI with IT nicardipine treatment was 0.61 (95% confidence interval [CI] 0.44–0.84), and the OR to have a favorable functional outcome (modified Rankin Scale score ≤ 2) was 2.17 (95% CI 1.61–2.91). CONCLUSIONS IT nicardipine was associated with improved outcome and reduced DCI compared with propensity-matched controls. There was an increased need for permanent CSF diversion but no other safety issues. These data should be considered when selecting medications and treatments to study in future randomized controlled clinical trials for SAH.
- Published
- 2020
22. Intrathecal Nicardipine for Cerebral Vasospasm Post Subarachnoid Hemorrhage – a Retrospective Analysis and Propensity-Based Comparison
- Author
-
Owen Samuels, Kathleen S Martin, Subin Mathew, Krista Garner, Feras Akbik, C. Michael Cawley, Lisa Danyluk, Amit Pujari, Chen Feng, Jacqueline Kraft, David Pearce, Daniel L Barrow, Jennifer Kolenda, Yajun Mei, Alexis Taylor, Ofer Sadan, R Loch Macdonald, Hannah Waddel, Pouya Ameli, Reneé H. Moore, Blessing N.R. Jaja, Cederic Pimentel, and William Asbury
- Subjects
Subarachnoid hemorrhage ,business.industry ,Nicardipine ,Vasospasm ,Odds ratio ,medicine.disease ,Clinical trial ,Cerebral vasospasm ,Anesthesia ,Propensity score matching ,Medicine ,business ,Adverse effect ,medicine.drug - Abstract
Background and PurposeCerebral vasospasm and delayed cerebral ischemia (DCI) contribute to poor outcome following subarachnoid hemorrhage (SAH). With the paucity of effective treatments, we describe our experience with intrathecal (IT) nicardipine for this indication.MethodsPatients admitted to Emory University Hospital Neuroscience ICU between 2012-2017 with non-traumatic SAH, either aneurysmal or idiopathic, were included in the analysis. This patient cohort was compared using a propensity-score model to patients in the SAH international trialist (SAHIT) repository who did not receive intrathecal nicardipine. The primary outcome was DCI. Secondary outcomes were long-term functional outcome and adverse events.ResultsThe analysis included 1,351 patients, 422 of whom were diagnosed with cerebral vasospasm and treated with IT nicardipine. When compared with patients with no vasospasm (n=859) the treated group was younger (51.1±12.4 vs. 56.7±14.1, p0.1) yet higher rates of VP shunting were noted (19.9% vs. 8.8%, pConclusionsIT nicardipine was associated with improved outcome and reduced DCI compared with propensity matched controls. There was an increased need for permanent CSF diversion but no other safety issues. This data should be considered when selecting medications and treatments to study in future randomized controlled clinical trial for SAH.
- Published
- 2020
23. Endovascular sacrifice of the proximal posterior inferior cerebellar artery for treatment of ruptured intracranial aneurysms
- Author
-
Jonathan A Grossberg, Nealen G. Laxpati, Brian M. Howard, C. Michael Cawley, James G. Malcolm, Ali Alawieh, and Frank C. Tong
- Subjects
Male ,medicine.medical_specialty ,Medullary cavity ,Vertebral artery ,Aneurysm, Ruptured ,Aneurysm ,Modified Rankin Scale ,medicine.artery ,Cerebellum ,medicine ,Humans ,Pica (disorder) ,Stroke ,Vertebral Artery ,Aged ,Retrospective Studies ,business.industry ,Endovascular Procedures ,Intracranial Aneurysm ,General Medicine ,Middle Aged ,medicine.disease ,Surgery ,Posterior inferior cerebellar artery ,Female ,Neurology (clinical) ,medicine.symptom ,business ,Perfusion - Abstract
BackgroundRuptured aneurysms of the intracranial vertebral artery (VA) or posterior inferior cerebellar artery (PICA) are challenging to treat as they are often dissecting aneurysms necessitating direct sacrifice of the diseased segment, which is thought to carry high morbidity due to brainstem and cerebellar stroke. However, relatively few studies evaluating outcomes following VA or proximal PICA sacrifice exist. We sought to determine the efficacy and outcomes of endovascular VA/PICA sacrifice.MethodsA retrospective series of ruptured VA/PICA aneurysms treated by endovascular sacrifice of the VA (including the PICA origin) or proximal PICA is reviewed. Collected data included demographic, radiologic, clinical, and disability information.ResultsTwenty-one patients were identified. Median age was 57 years (IQR 11); 15 were female. The Hunt and Hess grade was mostly 3 and 4 (18/21). Seven cases (33%) involved VA-V4 at the PICA take-off, and 14 cases (67%) involved the PICA exclusively. For VA pathology, V4 was sacrificed in all cases, while for PICA pathology, sacrificed segments included anterior medullary (4/14), lateral medullary (7/14), and tonsillomedullary (3/14) segments. Four patients went to hospice (19%). Twelve patients (57%) had evidence of stroke on follow-up imaging: cerebellar (8), medullary (1), and both (3). One patient required suboccipital decompression for brainstem compression. No aneurysm re-rupture occurred. Median discharge modified Rankin Scale score was 2.0 (IQR 2), which decreased to 1.0 (IQR 1) at median follow-up of 6.5 months (IQR 23).ConclusionsEndovascular sacrifice of V4 or PICA aneurysms may carry less morbidity than previously thought, and is a viable alternative for poor surgical candidates or those with good collateral perfusion.
- Published
- 2020
24. Endovascular Treatment of Posterior Cerebral Artery Aneurysms With Flow Diversion: Case Series and Systematic Review
- Author
-
DeWitte T. Cross, Jonathan A Grossberg, Anil K. Roy, Mudassar Kamran, Brian M. Howard, Joshua W. Osbun, Yasha Kayan, Adam N. Wallace, C. Michael Cawley, Akash P. Kansagra, Christopher J. Moran, Matthew J. Austin, Jacques E. Dion, and Josser E Delgado Almandoz
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Infarction ,Fusiform Aneurysm ,Posterior cerebral artery ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Aneurysm ,Blood vessel prosthesis ,medicine.artery ,Occlusion ,medicine ,Humans ,cardiovascular diseases ,Embolization ,Aged ,Retrospective Studies ,business.industry ,Endovascular Procedures ,Angiography ,Intracranial Aneurysm ,Middle Aged ,medicine.disease ,Embolization, Therapeutic ,Thrombosis ,Blood Vessel Prosthesis ,Surgery ,Treatment Outcome ,cardiovascular system ,Female ,Neurology (clinical) ,business ,030217 neurology & neurosurgery ,Follow-Up Studies - Abstract
Background Flow diversion of posterior cerebral artery (PCA) aneurysms has not been widely reported, possibly owing to concerns regarding parent vessel size and branch vessel coverage. Objective To examine the safety and effectiveness of PCA aneurysm flow diverter treatment. Methods Retrospective review of PCA aneurysms treated with the Pipeline Embolization Device (PED; Medtronic Inc, Dublin, Ireland) at 3 neurovascular centers, including periprocedural complications and clinical and angiographic outcomes. Systematic review of the literature identified published reports of PCA aneurysms treated with flow diversion. Rates of aneurysm occlusion and complications were calculated, and outcomes of saccular and fusiform aneurysm treatments were compared. Results Ten PCA aneurysms in 9 patients were treated with the PED. There were 2 intraprocedural thromboembolic events (20%), including 1 symptomatic infarction and 1 delayed PED thrombosis. Eight of 10 patients returned to or improved from their baseline functional status. Complete aneurysm occlusion with parent vessel preservation was achieved in 75% (6/8) of cases at mean follow-up of 16.7 mo. Eleven of 12 (92%) major branch vessels covered by a PED remained patent. Including the present study, systematic review of 15 studies found a complete aneurysm occlusion rate of 88% (30/34) and complication rate of 26% (10/38), including 5 symptomatic ischemic strokes (13%; 5/38). Fusiform aneurysms more frequently completely occluded compared with saccular aneurysms (100% vs 70%; P = .03) but were associated with a higher complication rate (43% vs 9%; P = .06). Conclusion The safety and effectiveness profile of flow diverter treatment of PCA aneurysms may be acceptable in select cases.
- Published
- 2018
25. Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Multi-Center Experience of 154 Consecutive Embolizations
- Author
-
Mandy J. Binning, Brian T. Jankowitz, Howard A. Riina, Peter Kan, David J. Langer, Jan-Karl Burkhardt, Timothy M. Robinson, Ricardo A. Hanel, Brian M. Howard, Ramesh Grandhi, Visish M. Srinivasan, C. Michael Cawley, Rafael Ortiz, Stephen R. Chen, Mohamed M. Salem, Michael R. Levitt, Aditya S Pandey, Christopher S. Ogilvy, Jonathan Lena, Farhan Siddiq, Elad I. Levy, Justin M. Moore, Aditya Srivatsan, Alejandro M Spiotta, Georgios A Maragkos, Jeremiah N. Johnson, Alexander A. Khalessi, Bradley A. Gross, Omar Tanweer, Sami Al Kasab, Ajith J. Thomas, Cory M. Kelly, Andrew J. Ringer, and Jacob Cherian
- Subjects
Male ,medicine.medical_specialty ,medicine.medical_treatment ,Radiography ,Middle meningeal artery ,Hematoma ,Chronic subdural hematoma ,Modified Rankin Scale ,medicine.artery ,medicine ,Humans ,Embolization ,Aged ,business.industry ,Stroke scale ,Mortality rate ,Endovascular Procedures ,Middle Aged ,medicine.disease ,Embolization, Therapeutic ,Meningeal Arteries ,Surgery ,Treatment Outcome ,Hematoma, Subdural, Chronic ,Female ,Neurology (clinical) ,business - Abstract
Background Middle meningeal artery (MMA) embolization has emerged as a promising treatment for chronic subdural hematoma (cSDH). Objective To determine the safety and efficacy of MMA embolization. Methods Consecutive patients who underwent MMA embolization for cSDH (primary treatment or recurrence after conventional surgery) at 15 centers were included. Clinical details and follow-up were collected prospectively. Primary clinical and radiographic outcomes were the proportion of patients requiring additional surgical treatment within 90 d after index treatment and proportion with > 50% cSDH thickness reduction on follow-up computed tomography imaging within 90 d. National Institute of Health Stroke Scale and modified Rankin Scale were also clinical outcomes. Results A total of 138 patients were included (mean age: 69.8, 29% female). A total of 15 patients underwent bilateral interventions for 154 total embolizations (66.7% primary treatment). At presentation, 30.4% and 23.9% of patients were on antiplatelet and anticoagulation therapy, respectively. Median admission cSDH thickness was 14 mm. A total of 46.1% of embolizations were performed under general anesthesia, and 97.4% of procedures were successfully completed. A total of 70.2% of embolizations used particles, and 25.3% used liquid embolics with no significant outcome difference between embolization materials (P > .05). On last follow-up (mean 94.9 d), median cSDH thickness was 4 mm (71% median thickness reduction). A total of 70.8% of patients had >50% improvement on imaging (31.9% improved clinically), and 9 patients (6.5%) required further cSDH treatment. There were 16 complications with 9 (6.5%) because of continued hematoma expansion. Mortality rate was 4.4%, mostly unrelated to the index procedure but because of underlying comorbidities. Conclusion MMA embolization may provide a safe and efficacious minimally invasive alternative to conventional surgical techniques.
- Published
- 2021
26. Comparison Between CTA and Digital Subtraction Angiography in the Diagnosis of Ruptured Aneurysms
- Author
-
C. Michael Cawley, Gustavo Pradilla, Lucas R Philipp, Jonathan A Grossberg, Brendan P. Lovasik, Jason H Boulter, D Jay McCracken, Daniel L. Barrow, Courtney McCracken, Arsalaan Salehani, and Sameer H. Halani
- Subjects
medicine.medical_specialty ,Subarachnoid hemorrhage ,Ruptured aneurysms ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Aneurysm ,medicine.artery ,Medicine ,cardiovascular diseases ,medicine.diagnostic_test ,business.industry ,musculoskeletal, neural, and ocular physiology ,Small sample ,Retrospective cohort study ,Digital subtraction angiography ,medicine.disease ,Angiography ,cardiovascular system ,Surgery ,Neurology (clinical) ,Radiology ,Internal carotid artery ,business ,psychological phenomena and processes ,030217 neurology & neurosurgery - Abstract
BACKGROUND Computerized tomography angiography (CTA) is commonly used to diagnose ruptured cerebral aneurysms with sensitivities reported as high as 97% to 100%. Studies validating CTA accuracy in the setting of subarachnoid hemorrhage (SAH) are scarce and limited by small sample sizes. OBJECTIVE To evaluate the diagnostic accuracy of CTA in detecting intracranial aneurysms in the setting of SAH. METHODS A single-center, retrospective cohort of 643 patients was reviewed. A total of 401 patients were identified whose diagnostic workup included both CTA and confirmatory digital subtraction angiography (DSA). Aneurysms missed by CTA but diagnosed by DSA were further stratified by size and location. RESULTS Three hundred and thirty aneurysms were detected by CTA while DSA detected a total of 431 aneurysms. False positive CTA results were seen for 24 aneurysms. DSA identified 125 aneurysms that were missed by CTA and 83.2% of those were
- Published
- 2017
27. Wider Adoption of Flow Diversion for Intracranial Aneurysms
- Author
-
C. Michael Cawley, Raphael Guzman, and Spiros Blackburn
- Subjects
Advanced and Specialized Nursing ,medicine.medical_specialty ,Aneurysm ,Flow diversion ,business.industry ,medicine ,Neurology (clinical) ,Cardiology and Cardiovascular Medicine ,medicine.disease ,business ,Surgery - Published
- 2019
28. Book Review: Stroke Revisited: Hemorrhagic Stroke
- Author
-
C. Michael Cawley and Nealen G. Laxpati
- Subjects
medicine.medical_specialty ,business.industry ,Emergency medicine ,medicine ,Surgery ,Neurology (clinical) ,medicine.disease ,business ,Stroke - Published
- 2019
29. Hemodynamic Fate of the Precommunicating Anterior Cerebral Artery Is Predicted by Vessel Dominance After Pipeline Embolization Device Deployment Across the Internal Carotid Artery Terminus
- Author
-
Frank C. Tong, Alhamza R Al-Bayati, Jacque E. Dion, Jonathan A Grossberg, Brian M. Howard, C. Michael Cawley, Susana L Skukalek, Jacob Cherian, and Amit Pujari
- Subjects
Adult ,Male ,medicine.medical_specialty ,Anterior Cerebral Artery ,medicine.medical_treatment ,Hemodynamics ,03 medical and health sciences ,Blood Vessel Prosthesis Implantation ,0302 clinical medicine ,Interquartile range ,medicine.artery ,Anterior cerebral artery ,Medicine ,Humans ,Embolization ,Aged ,Retrospective Studies ,medicine.diagnostic_test ,business.industry ,Stent ,Intracranial Aneurysm ,Middle Aged ,Embolization, Therapeutic ,Blood Vessel Prosthesis ,Treatment Outcome ,030220 oncology & carcinogenesis ,Cerebrovascular Circulation ,Angiography ,Middle cerebral artery ,Surgery ,Female ,Neurology (clinical) ,Radiology ,Internal carotid artery ,business ,030217 neurology & neurosurgery ,Carotid Artery, Internal ,Follow-Up Studies - Abstract
The Pipeline embolization device (PED) is commonly used for the treatment of distal internal carotid artery (ICA) aneurysms, which often require placing the stent across the origin of the precommunicating segment of the anterior cerebral artery (ACA-A1). We sought to characterize the clinical and angiographic consequences of this maneuver.We performed a retrospective review of a prospectively collected database of patients treated with the PED at a single academic center from 2011 to 2017 to find patients for whom the PED was extended across the origin of the ACA-A1. The patient demographic data, pretreatment angiographic imaging findings, sizing of the bilateral A1 and ipsilateral M1 segment of the middle cerebral artery (MCA-M1), and follow-up angiographic and clinical imaging findings were recorded.A total of 27 patients were included in the present study (8 men and 19 women; age, 52 ± 14.9 years). Follow-up angiography was conducted at a median of 9.2 months (interquartile range, 6; range, 5-84). The covered A1 segment was patent in 17 patients (63%). The covered ACA-A1/ipsilateral MCA-M1 ratio was 1.43 times greater for the patent ACA-A1 segments than those that were occluded (P = 0.0006). Similarly, the covered ACA-A1/contralateral ACA-A1 ratio was significantly larger statistically (1.64; P0.0001) for the patent ACA-A1 segments than that for those that were occluded. None of the patients developed clinical or radiographic signs of ACA stroke. The modified Rankin scale worsened for 1 patient during follow-up owing to a further decline of presenting vision loss.The PED can be used to treat aneurysms with deployment from the MCA-M1 to the ICA without resulting in ACA stroke. Ipsilateral A1 segment dominance might be predictive of continued blood flow into the ACA after deployment at this location.
- Published
- 2019
30. Flow Diversion for Treatment of Intracranial Aneurysms in Pediatric Patients: Multicenter Case Series
- Author
-
Mohammad Anadani, Jeremiah N. Johnson, Travis M. Dumont, Peng R Chen, Andrew F. Ducruet, Ciaran J. Powers, Jonathan A Grossberg, Ahmed Saied, C. Michael Cawley, Kyle M Fargen, Ajit S. Puri, Ramesh Grandhi, Demetrius K. Lopes, Felipe C. Albuquerque, Sandi Lam, Stephen R. Chen, Alejandro M Spiotta, Jacob Cherian, Louis Kim, Peter Kan, Visish M. Srinivasan, Ahmed Cheema, Adam S Arthur, J Mocco, Michael T. Froehler, Reade De Leacy, Ricardo A. Hanel, and Cory M. Kelly
- Subjects
Male ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Aneurysm, Ruptured ,Young Adult ,Aneurysm ,Older patients ,Modified Rankin Scale ,Occlusion ,Medicine ,Humans ,In patient ,cardiovascular diseases ,Embolization ,Adverse effect ,Child ,Retrospective Studies ,Flow diversion ,business.industry ,Endovascular Procedures ,Intracranial Aneurysm ,medicine.disease ,Embolization, Therapeutic ,Surgery ,Blood Vessel Prosthesis ,Cerebral Angiography ,Treatment Outcome ,Child, Preschool ,cardiovascular system ,Female ,Neurology (clinical) ,business ,Follow-Up Studies - Abstract
BACKGROUND Though the Pipeline Embolization Device (Medtronic) is approved for use in adults 22 yr and older, the high efficacy and long-term durability of the device is attractive for treatment of intracranial aneurysms in younger patients who often have aneurysms less amenable to traditional endovascular treatments. OBJECTIVE To report technical, angiographic, and clinical outcomes in patients aged 21 or below undergoing flow-diversion treatment for intracranial aneurysms. METHODS Retrospective review across 16 institutions identified 39 patients aged 21 or below undergoing 46 treatment sessions with Pipeline Embolization Device placement between 2012 and 2018. A total of 50 intracranial aneurysms were treated. Details regarding patient demographics, aneurysm characteristics, treatment considerations, clinical outcomes, and aneurysm occlusion were obtained and analyzed in a multicenter database. RESULTS A total of 70% of patients were male. Nonsaccular morphology was seen in half of identified aneurysms. Six aneurysms were giant, and five patients were treated acutely after ruptured presentation. Eight patients were younger than 10 yr of age. Complete aneurysm occlusion was seen in 74% of treated aneurysms. Three aneurysms (6%) were retreated. A total of 83% of patients had a modified Rankin Scale scores of ≤2 at last clinical follow-up. There were 2 early mortalities (4.3%) in the immediate postprocedure period because of rerupture of a treated ruptured aneurysm. No recanalization of a previously occluded aneurysm was observed. CONCLUSION Flow-diversion treatment is a safe and effective treatment for intracranial aneurysms in patients younger than 22 yr. Rates of complete aneurysm occlusion and adverse events are comparable for rates seen in older patients.
- Published
- 2019
31. Combined reconstructive and deconstructive endovascular approach for bilateral vertebral artery dissection with subarachnoid hemorrhage
- Author
-
Brian M. Howard, Thomas P Madaelil, Jonathan A Grossberg, C. Michael Cawley, Frank C. Tong, and Jacob Cherian
- Subjects
Adult ,Male ,medicine.medical_specialty ,Subarachnoid hemorrhage ,Vertebral artery dissection ,medicine.medical_treatment ,030218 nuclear medicine & medical imaging ,Ventriculostomy ,03 medical and health sciences ,Pseudoaneurysm ,0302 clinical medicine ,medicine ,Humans ,Endovascular treatment ,Coil embolization ,Vertebral Artery Dissection ,business.industry ,Endovascular Procedures ,Stent ,General Medicine ,Plastic Surgery Procedures ,Subarachnoid Hemorrhage ,medicine.disease ,Combined Modality Therapy ,Surgery ,Stenosis ,Bilateral vertebral artery dissection ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
The video highlights a challenging case of bilateral vertebral artery dissection presenting with subarachnoid hemorrhage. The patient was found to have a critical flow-limiting stenosis in his dominant right vertebral artery and a ruptured pseudoaneurysm in his left vertebral artery. A single-stage endovascular treatment with stent reconstruction of the right vertebral artery and coil embolization sacrifice of the left side was performed. The case highlights the rationale for treatment and potential alternative strategies.The video can be found here: https://youtu.be/e0U_JE2jISw.
- Published
- 2018
32. Middle meningeal artery embolization treatment of nonacute subdural hematomas in the elderly: a multiinstitutional experience of 151 cases
- Author
-
Jonathan P Scoville, Ajith J. Thomas, Elad I. Levy, Ramesh Grandhi, Andrew J. Ringer, Evan Joyce, Brian T. Jankowitz, Aditya S. Pandey, Alexander A. Khalessi, C. Michael Cawley, Omar Tanweer, Philipp Taussky, Rafael Ortiz, Mandy J. Binning, Christopher S. Ogilvy, Bradley A. Gross, Ricardo A. Hanel, Alejandro M Spiotta, Howard A. Riina, David J. Langer, Michael T. Bounajem, Michael R. Levitt, and Peter Kan
- Subjects
medicine.medical_specialty ,Middle meningeal artery ,medicine.medical_treatment ,Population ,Subgroup analysis ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Recurrence ,medicine.artery ,medicine ,Humans ,Embolization ,education ,Aged ,Retrospective Studies ,Aged, 80 and over ,education.field_of_study ,business.industry ,Incidence (epidemiology) ,General Medicine ,Perioperative ,Subdural Hematomas ,Embolization, Therapeutic ,Meningeal Arteries ,humanities ,Surgery ,Treatment Outcome ,Hematoma, Subdural, Chronic ,Concomitant ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
OBJECTIVEThe incidence of already common chronic subdural hematomas (CSDHs) and other nonacute subdural hematomas (NASHs) in the elderly is expected to rise as the population ages over the coming decades. Surgical management is associated with recurrence and exposes elderly patients to perioperative and operative risks. Middle meningeal artery (MMA) embolization offers the potential for a minimally invasive, less morbid treatment in this age group. The clinical and radiographic outcomes after MMA embolization treatment for NASHs have not been adequately described in elderly patients. In this paper, the authors describe the clinical and radiographic outcomes after 151 cases of MMA embolization for NASHs among 121 elderly patients.METHODSIn a retrospective review of a prospectively maintained database across 15 US academic centers, the authors identified patients aged ≥ 65 years who underwent MMA embolization for the treatment of NASHs between November 2017 and February 2020. Patient demographics, comorbidities, clinical and radiographic factors, treatment factors, and clinical outcomes were abstracted. Subgroup analysis was performed comparing elderly (age 65–79 years) and advanced elderly (age > 80 years) patients.RESULTSMMA embolization was successfully performed in 98% of NASHs (in 148 of 151 cases) in 121 patients. Seventy elderly patients underwent 87 embolization procedures, and 51 advanced elderly patients underwent 64 embolization procedures. Elderly and advanced elderly patients had similar rates of embolization for upfront (46% vs 61%), recurrent (39% vs 33%), and prophylactic (i.e., with concomitant surgical intervention; 15% vs 6%) NASH treatment. Transfemoral access was used in most patients, and the procedure time was approximately 1 hour in both groups. Particle embolization with supplemental coils was most common, used in 51% (44/87) and 44% (28/64) of attempts for the elderly and advanced elderly groups, respectively. NASH thickness decreased significantly from initial thickness to 6 weeks, with additional decrease in thickness observed in both groups at 90 days. At longest follow-up, the treated NASHs had stabilized or improved in 91% and 98% of the elderly and advanced elderly groups, respectively, with > 50% improvement seen in > 60% of patients for each group. Surgical rescue was necessary in 4.6% and 7.8% of cases, and the overall mortality was 8.6% and 3.9% for elderly and advanced elderly patients, respectively.CONCLUSIONSMMA embolization can be used safely and effectively as an alternative or adjunctive minimally invasive treatment for NASHs in elderly and advanced elderly patients.
- Published
- 2020
33. Treatment of complex anterior cerebral artery aneurysms with Pipeline flow diversion: mid-term results
- Author
-
Guilherme Dabus, Jonathan A. Grossberg, Italo Linfante, Jacques E. Dion, Ricardo A. Hanel, Ajay K. Wakhloo, Pedro Aguilar-Salinas, Ajit S. Puri, Douglas Gonsales, Eric Sauvageau, and C. Michael Cawley
- Subjects
Adult ,Male ,medicine.medical_specialty ,Subarachnoid hemorrhage ,Anterior Cerebral Artery ,medicine.medical_treatment ,Mid term results ,Neurosurgical Procedures ,030218 nuclear medicine & medical imaging ,Blood Vessel Prosthesis Implantation ,03 medical and health sciences ,0302 clinical medicine ,Aneurysm ,medicine.artery ,medicine ,Anterior cerebral artery ,Humans ,cardiovascular diseases ,Embolization ,Infarction, Anterior Cerebral Artery ,Intraparenchymal hemorrhage ,Aged ,Cerebral Hemorrhage ,Retrospective Studies ,Flow diverter ,medicine.diagnostic_test ,business.industry ,Intracranial Aneurysm ,Cerebral Infarction ,General Medicine ,Middle Aged ,medicine.disease ,Blood Vessel Prosthesis ,Cerebral Angiography ,Surgery ,Angiography ,Female ,Neurology (clinical) ,Radiology ,business ,Magnetic Resonance Angiography ,030217 neurology & neurosurgery - Abstract
BackgroundThe off-label use of flow diverters in the treatment of distal aneurysms continues to be debated.ObjectiveTo report our multicenter experience in the treatment of complex anterior cerebral artery aneurysms with the Pipeline embolization device (PED).MethodsThe neurointerventional databases of the four participating institutions were retrospectively reviewed for aneurysms treated with PED between October 2011 and January of 2016. All patients treated for anterior cerebral artery aneurysms were included in the analysis. Clinical presentation, location, type, vessel size, procedural complications, clinical and imaging follow-up were included in the analysis.ResultsTwenty patients (13 female) with 20 aneurysms met the inclusion criteria in our study. Fifteen aneurysms were classified as saccular and five as fusiform (mean size 7.3 mm). Thirteen aneurysms were located in the anterior communicating region (ACOM or A1/2 junction), six were A2-pericallosal, and one was located in the A1 segment. Six patients had presented previously with subarachnoid hemorrhage and had their aneurysms initially clipped or coiled. There was one minor event (a small caudate infarct) and one major event (intraparenchymal hemorrhage). Sixteen of the 20 patients had angiographic follow-up (mean 10 months). Eleven aneurysms were completely occluded, one had residual neck, and four had residual aneurysm filling.ConclusionsThe treatment of complex anterior cerebral artery aneurysms with the PED as an alternative for patients who are not good candidates for conventional methods is technically feasible and safe. Mid-term results are promising but larger series with long-term follow-up are required to assess its effectiveness.
- Published
- 2016
34. Resolution of Oculomotor Nerve Palsy Secondary to Posterior Communicating Artery Aneurysms
- Author
-
Justin M. Caplan, D Jay McCracken, Jacques E. Dion, C. Michael Cawley, Courtney McCracken, Daniel L. Barrow, Gustavo Pradilla, Brendan P. Lovasik, Nefize Turan, Rafael J. Tamargo, and Raul G Nogueira
- Subjects
Adult ,Male ,medicine.medical_specialty ,Subarachnoid hemorrhage ,medicine.medical_treatment ,Aneurysm, Ruptured ,Aneurysm ,medicine.artery ,Oculomotor Nerve Diseases ,Humans ,Medicine ,Prospective Studies ,Posterior communicating artery ,Embolization ,Oculomotor nerve palsy ,Aged ,Retrospective Studies ,business.industry ,Oculomotor nerve ,Intracranial Aneurysm ,Recovery of Function ,Clipping (medicine) ,Middle Aged ,Microsurgery ,medicine.disease ,Embolization, Therapeutic ,Surgery ,Treatment Outcome ,Female ,Neurology (clinical) ,business - Abstract
Background Previous studies have attempted to determine the best treatment for oculomotor nerve palsy (ONP) secondary to posterior communicating artery (PCoA) aneurysms, but have been limited by small sample sizes and limited treatment. Objective To analyze the treatment of ONP secondary to PCoA with both coiling and clipping in ruptured and unruptured aneurysms. Methods Data from 2 large academic centers was retrospectively collected over 22 years, yielding a total of 93 patients with ONP secondary to PCoA aneurysms. These patients were combined with 321 patients from the literature review for large data analyses. Onset symptoms, recovery, and time to resolution were evaluated with respect to treatment and aneurysm rupture status. Results For all patients presenting with ONP (n = 414) 56.6% of those treated with microsurgical clipping made a full recovery vs 41.5% of those treated with endovascular coil embolization (P = .02). Of patients with a complete ONP (n = 229), full recovery occurred in 47.3% of those treated with clipping but in only 20% of those undergoing coiling (P = .01). For patients presenting with ruptured aneurysms (n = 130), full recovery occurred in 70.9% compared with 49.3% coiled patients (P = .01). Additionally, although patients with full ONP recovery had a median time to treatment of 4 days, those without full ONP recovery had a median time to treatment of 7 days (P = .01). Conclusion Patients with ONP secondary to PCoA aneurysms treated with clipping showed higher rates of full ONP resolution than patients treated with coil embolization. Larger prospective studies are needed to determine the true potential of recovery associated with each treatment. Abbreviations EUH, Emory University HospitalIQR, interquartile rangeJHU, Johns Hopkins UniversitymRS, modified Rankin ScaleONP, oculomotor nerve palsyPCoA, posterior communicating arterySAH, subarachnoid hemorrhage.
- Published
- 2015
35. Microsurgical Treatment of Cerebral Aneurysms After Previous Endovascular Therapy: Single-Center Series and Systematic Review
- Author
-
Jonathan A Grossberg, C. Michael Cawley, Anil K. Roy, Lucas R Philipp, Brian M. Howard, and Daniel L. Barrow
- Subjects
Reoperation ,medicine.medical_specialty ,Microsurgery ,Subarachnoid hemorrhage ,Single Center ,Endovascular therapy ,03 medical and health sciences ,0302 clinical medicine ,Aneurysm ,Modified Rankin Scale ,Medicine ,Humans ,cardiovascular diseases ,business.industry ,Endovascular Procedures ,Intracranial Aneurysm ,Odds ratio ,medicine.disease ,Confidence interval ,Microsurgical treatment ,Surgery ,030220 oncology & carcinogenesis ,cardiovascular system ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
Background Since its introduction in the early 1990s, endovascular treatment of cerebral aneurysms has had a steady upward trend and is the primary mode of treatment for most intracranial aneurysms. Concurrently, the need for retreatment of aneurysms after previous endovascular treatment has continued to increase, some of which can only be treated with microsurgical techniques. The factors that dictate outcomes in this group of patients are incompletely understood. Objective To study factors contributing to patient outcomes after microsurgical treatment of aneurysms with previous endovascular treatment. Methods The records of the senior author (D.L.B.) since 2002 were retrospectively reviewed for aneurysms treated after previous endovascular treatment. Demographics, treatment details, and imaging were reviewed for all patients. A systematic review of the literature on microsurgical treatment of aneurysms previously treated by endovascular therapy was also conducted. Results A total of 91 patients were identified from the retrospective review. Mean age at the time of initial treatment was 49 ± 12.68 years. Most patients initially presented with subarachnoid hemorrhage before initial endovascular treatment, with only 11 patients (12%) presenting with incidentally discovered lesions. Modified Rankin Scale score at discharge after initial treatment was good (0–3) in 81.4% of cases. Functional outcomes at the last known follow-up showed a modified Rankin Scale score of 0–3 in 77 patients (84.6%). Only aneurysm neck size was found to be a significant predictor of surgical complications (Wald χ2 = 10.79; P = 0.0010) with an odds ratio of 2.32 (95% confidence interval, 1.40–3.83) for a 2-mm increase in neck size. Systematic review identified 37 studies who were used to pool data on 370 patients. Although type of surgery was identified as a predictor of poor outcomes, this was significantly confounded by Hunt and Hess grade in the systematic review. Conclusions Favorable outcomes can be obtained even for highly complex cerebral aneurysms that have failed endovascular treatment at high-volume cerebrovascular centers. Initial presentation grade and aneurysm size are important predictors of final patient outcomes.
- Published
- 2018
36. 'Plug and pipe' strategy for treatment of ruptured intracranial aneurysms
- Author
-
Jacques E. Dion, Jonathan A Grossberg, C. Michael Cawley, Thomas P Madaelil, Jason M. Frerich, Brian M. Howard, and Frank C. Tong
- Subjects
Adult ,Male ,medicine.medical_specialty ,Subarachnoid hemorrhage ,Self Expandable Metallic Stents ,Aneurysm, Ruptured ,030218 nuclear medicine & medical imaging ,Aneurysm rupture ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Aneurysm ,Occlusion ,medicine ,Humans ,Prospective Studies ,Aged ,Retrospective Studies ,Aged, 80 and over ,business.industry ,Endovascular Procedures ,Retrospective cohort study ,Intracranial Aneurysm ,General Medicine ,Middle Aged ,Subarachnoid Hemorrhage ,medicine.disease ,Surgical Instruments ,Embolization, Therapeutic ,Surgery ,Treatment Outcome ,Functional status ,Female ,Neurology (clinical) ,Operative risk ,business ,030217 neurology & neurosurgery ,Recovery phase ,Follow-Up Studies - Abstract
BackgroundAneurysmal subarachnoid hemorrhage is a potentially devastating condition, and among the first priorities of treatment is aneurysm occlusion to prevent re-hemorrhage. An emerging strategy to treat patients whose aneurysms are not ideal for surgical or endovascular treatment is subtotal coiling followed by flow diversion in the recovery phase or ‘plug and pipe’. However, data regarding the safety and efficacy of this strategy are lacking.MethodsA retrospective cohort study was performed to evaluate the efficacy and safety of ‘plug and pipe’. All patients with a ruptured intracranial aneurysm intentionally, subtotally treated by coiling in the acute stage followed by flow diversion after recovery, were included. The primary outcome was re-hemorrhage. Secondary outcomes included aneurysm occlusion and functional status. Complications were reviewed.Results22 patients were included. No patient suffered a re-hemorrhage, either in the interval between coiling and flow diversion or in follow-up. The median interval between aneurysm rupture and flow diversion was 3.5 months. Roy–Raymond (R-R) class I or II occlusion was achieved in 91% of target aneurysms at the last imaging follow-up (15/22(68%) R-R 1 and 5/22(23%) R-R 2). Complications occurred in 2 (9%) patients, 1 of which was neurological.ConclusionsOverall, these data suggest that subtotal coiling of ruptured intracranial aneurysms followed by planned flow diversion is both safe and effective. Patients who may most benefit from ‘plug and pipe’ are those with aneurysms that confer high operative risk and those whose severity of medical illness increases the risk of microsurgical clip ligation.
- Published
- 2018
37. Abstract TP130: Recurrent Hemispheric Stroke Syndromes in Symptomatic Atherosclerotic Internal Carotid Artery Occlusions: The COSS Trial
- Author
-
C. Michael Cawley, Fadi Nahab, Daniel L. Barrow, Haseeb Rahman, Harold P. Adams, Colin P. Derdeyn, Robert L. Grubb, William J. Powers, and M. Bridget Zimmerman
- Subjects
Advanced and Specialized Nursing ,medicine.medical_specialty ,Hemispheric stroke ,business.industry ,Carotid arteries ,medicine.disease ,medicine.artery ,Internal medicine ,Baseline characteristics ,medicine ,Cardiology ,Neurology (clinical) ,Internal carotid artery ,Cardiology and Cardiovascular Medicine ,business ,Stroke - Abstract
Background: There are limited data on the baseline characteristics and clinical outcomes of patients who have recurrent hemispheric syndromes in the territory of symptomatic atherosclerotic internal carotid artery occlusion (AICAO). Methods: Baseline characteristics and clinical outcomes were compared between patients with (rHEM+) and without (rHEM-) recurrent ipsilateral hemispheric syndromes at the time of randomization into the Carotid Occlusion Surgery Study (COSS) based on local investigator clinical impression. Results: Of 195 participants who were randomized, 100 (51%) were rHEM+ (50 in each study arm) and 95 were rHEM-(48 nonsurgical, 47 surgical). Baseline characteristics between rHEM+ and rHEM- participants were similar except that rHEM+ participants were more likely to have had a previous stroke prior to entry event (59% vs 22%, p < 0.001) and to have had TIA vs stroke as the entry event (61% vs 20%, p 0.10). For the nonsurgical participants, there was no statistically significant difference in the primary endpoint for those rHEM+ vs rHEM- (26.3% vs 18.9%, p=.410) Conclusion: Patients with recurrent hemispheric stroke syndromes enrolled in the COSS trial were more likely to have had previous stroke and to have TIAs as the entry event to randomization. Given the lack of surgical treatment benefit seen in these patients, early aggressive risk factor measures should be prioritized to reduce recurrent strokes, including blood pressure control which was associated with a 70% reduction in stroke in the nonsurgical group in COSS ( Neurology 2014; 82:1027-1032).
- Published
- 2018
38. Incompletely obliterated cranial arteriovenous fistulae are safely and effectively treated with adjuvant ε-aminocaproic acid
- Author
-
Jonathan A Grossberg, Jacques E. Dion, C. Michael Cawley, Frank C. Tong, Brian M. Howard, and Adam Prater
- Subjects
Adult ,Intracranial Arteriovenous Malformations ,Male ,medicine.medical_specialty ,Fistula ,medicine.medical_treatment ,Neurosurgical Procedures ,030218 nuclear medicine & medical imaging ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Adjuvant therapy ,medicine ,Humans ,Embolization ,Prospective Studies ,Aged ,Retrospective Studies ,business.industry ,Retrospective cohort study ,General Medicine ,Middle Aged ,medicine.disease ,Thrombosis ,Combined Modality Therapy ,Embolization, Therapeutic ,Surgery ,Treatment Outcome ,Cavernous sinus ,Aminocaproic Acid ,Arteriovenous Fistula ,Female ,Neurology (clinical) ,Radiology ,Aminocaproic acid ,business ,Complication ,Vascular Surgical Procedures ,030217 neurology & neurosurgery ,medicine.drug ,Follow-Up Studies - Abstract
BackgroundAdministration of ε-aminocaproic acid (εACA), as adjuvant therapy following incompletely embolized cranial dural arteriovenous (dAVFs) and direct carotid artery to cavernous sinus fistulae (CCFs), is a strategy to promote post-procedural thrombosis. However, the efficacy of εACA to treat incompletely obliterated dAVFs and CCFs has not been published. The purpose of this study was to determine if administration of εACA following incomplete embolization of cranial dAVFs or CCFs was associated with an increased likelihood of cure on follow-up imaging compared with patients not given adjuvant εACA.MethodsA retrospective cohort study was performed. All patients who underwent treatment of a dAVF or CCF at our institution between 1998 and 2016 were reviewed (n=262). Patients with residual shunting following the first attempted endovascular embolization were included in the analysis (n=52). The study groups were those treated with εACA following incomplete obliteration of the fistula and those who were not. The primary outcome was obliteration of the fistula on initial follow-up imaging. Complication rates between cohorts were compared.Results20 (38%) patients with incompletely obliterated fistulae were treated with adjuvant εACA. A trend towards an improved rate of complete obliteration on initial follow-up imaging was observed in the group treated with εACA (55% vs 34% in the group not treated with εACA, p=0.14). No difference in clinical outcomes or thromboembolic complications was observed between the groups.ConclusionsIn summary, these data suggest that administration of εACA is a safe adjuvant therapy in the management of cranial dAVFs and CCFs that are incompletely treated endovascularly.
- Published
- 2017
39. Microsurgical Management of a Spinal Dural Arteriovenous Fistula With Shared Blood Supply to the Artery of Adamkiewicz: 3-Dimensional Operative Video
- Author
-
C. Michael Cawley, Brian M. Howard, and Daniel L. Barrow
- Subjects
medicine.medical_specialty ,Dysesthesia ,medicine.diagnostic_test ,Tandem gait ,business.industry ,Fistula ,Arteriovenous fistula ,Neurological examination ,medicine.disease ,Spinal cord ,030218 nuclear medicine & medical imaging ,Surgery ,Conus medullaris ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,medicine.artery ,medicine ,Neurology (clinical) ,Artery of Adamkiewicz ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
The presented case is of a 65-yr-old gentleman referred for thoracic myelopathy. He developed bilateral, nondermatomal foot dysesthesia 14 mo prior to presentation, which progressed to numbness below the L3 level. He reported progressive gait instability, bilateral lower extremity weakness, and required a cane for ambulation. He subsequently developed urinary incontinence, while bowel function was spared. The neurological examination upon presentation revealed lower extremity strength was reduced to 4/5 in all major muscle groups bilaterally, while sensation and proprioception were reduced below the L3 level. Patellar and Achilles reflexes were not elicited and clonus was absent. Gait was unsteady and slow. The patient was not able to perform heel, toe and tandem gait. MRI revealed abnormal T2 hyper-intense signal and spinal cord expansion from T6 through the conus medullaris. Angiography revealed a dural arteriovenous fistula (dAVF) originating from the left T9 radicomedullary pedicle, which also supplied the Artery of Adamkiewicz (AoA). The patient underwent T8-10 laminectomies. Prior to disconnection of the fistula, an aneurysm clip was applied to the fistulous point and an indocyanine green video angiogram was completed to show that the fistula no longer opacified, but that the AoA remained patent, which was later confirmed with angiography. As of discharge, the patient's motor exam had improved substantially, though his sensory deficits persisted. This case demonstrates that surgical disconnection is requisite in the treatment of spinal dAVF that have a shared blood supply with the AoA, as embolization risks spinal cord infarction. The patient consented to presentation of this case in a de-identified fashion.
- Published
- 2018
40. Capillary Telangiectasias
- Author
-
Matthew R. Reynolds, Joshua W. Osbun, and C. Michael Cawley
- Published
- 2016
41. Microsurgical and endovascular management of pericallosal aneurysms
- Author
-
Daniel L. Barrow, Albert J. Schuette, Michael L. Lieber, Jacques E. Dion, Alejandro M Spiotta, C. Michael Cawley, Ferdinand K. Hui, Shaye I. Moskowitz, and Peter A. Rasmussen
- Subjects
Male ,medicine.medical_specialty ,International Subarachnoid Aneurysm Trial ,Subarachnoid hemorrhage ,medicine.medical_treatment ,Corpus Callosum ,Cohort Studies ,Aneurysm ,Modified Rankin Scale ,medicine ,Humans ,cardiovascular diseases ,Embolization ,Retrospective Studies ,Cerebral Revascularization ,business.industry ,Endovascular Procedures ,Disease Management ,Intracranial Aneurysm ,Retrospective cohort study ,Vasospasm ,General Medicine ,Middle Aged ,medicine.disease ,Hydrocephalus ,Surgery ,Radiography ,cardiovascular system ,Female ,Neurology (clinical) ,Radiology ,business ,Follow-Up Studies - Abstract
Background Pericallosal, or A2 bifurcation, aneurysms are an infrequently encountered cause of subarachnoid hemorrhage (SAH). While the International Subarachnoid Aneurysm Trial showed improved outcomes for patients with any ruptured anterior circulation aneurysm treated with embolization, there was also a higher recurrence rate for embolized aneurysms. Notably, there were relatively few pericallosal aneurysms. Objective Specific analysis of pericallosal aneurysms may help guide therapeutic decisions. Methods Retrospective analysis of patients who presented with proven saccular pericallosal aneurysms was performed at two institutions from 1999 to 2009. Patients were stratified according to presentation Hunt and Hess grades and modified Fisher scores, treatment modality and outcomes as well as development of vasospasm, hydrocephalus and required treatment. Results Eighty-eight patients with pericallosal aneurysms were identified. Sixty-two presented with SAH and 26 in elective fashion, 2 of whom had a prior history of SAH. Fifty-four patients underwent microsurgical repair and 32 endovascular repair. Patients presenting with SAH due to pericallosal aneurysm treated with an endovascular approach were more likely to have a good modified Rankin scale (mRS) (mRS 0–2 vs 3–6) (p=0.028), to make a complete recovery (mRS=0) (p=0.017) and were less likely to die (mRS=6) (p=0.026). Patients with electively treated pericallosal aneurysms did not have statistically significant differences in outcome between surgical and endovascular cohorts. Differences in secondary endpoints did not reach significance. Conclusion Patients with ruptured pericallosal aneurysms fare better with endovascular therapy, with better chance of complete recovery. Surgical and endovascular treatments of unruptured pericallosal aneurysms have similar results and outcome.
- Published
- 2011
42. Microsurgical Clip Ligation for Intracranial Aneurysms
- Author
-
Albert J. Schuette, C. Michael Cawley, and Daniel L. Barrow
- Subjects
medicine.medical_specialty ,business.industry ,medicine ,Clip ligation ,General Earth and Planetary Sciences ,business ,General Environmental Science ,Surgery - Published
- 2009
43. Clinical Differences Between Angiographically Negative, Diffuse Subarachnoid Hemorrhage and Perimesencephalic Subarachnoid Hemorrhage
- Author
-
Tomoko Tanaka, Ferdinand K. Hui, Y. Jonathan Zhang, Luis M. Tumialán, and C. Michael Cawley
- Subjects
Male ,medicine.medical_specialty ,Subarachnoid hemorrhage ,Critical Care ,Critical Care and Intensive Care Medicine ,Severity of Illness Index ,Mesencephalon ,Risk Factors ,Cerebrospinal fluid diversion ,Severity of illness ,medicine ,Humans ,Vasospasm, Intracranial ,cardiovascular diseases ,Retrospective Studies ,medicine.diagnostic_test ,business.industry ,Retrospective cohort study ,Vasospasm ,Subarachnoid Hemorrhage ,Prognosis ,medicine.disease ,Cerebral Angiography ,nervous system diseases ,Hydrocephalus ,Female ,Neurology (clinical) ,Radiology ,Tomography, X-Ray Computed ,business ,Perimesencephalic subarachnoid hemorrhage ,Cerebral angiography - Abstract
To identify prognostic factors for vasospasm, hydrocephalus, and clinical outcomes in patients with angiographically negative, non-traumatic, diffuse subarachnoid hemorrhage (d-SAH). Retrospective review of patients who experienced angiographically negative SAH at our institution over the past 6 years was undertaken. The patients were stratified based on grade at presentation, severity, and pattern of SAH on initial non-enhanced, computed tomography (CT) of the head into perimesencephalic and diffuse subtypes. The patients were further differentiated based on the development of vasospasm, hydrocephalus and required treatments, and clinical outcomes. Patients were excluded if a causative lesion was discovered subsequently. Ninety-four patients with angiographically negative SAH were identified. A total of 31 patients were considered to have the perimesencephalic (p-SAH) subtype, while 63 patients fit criteria for the diffuse (d-SAH) subtype. Compared to the p-SAH subtype, those patients with d-SAH subtype had significantly higher risk for complications related to SAH with an increased incidence of hydrocephalus (50.8% vs. 9.6%), requirement for external ventricular drainage (41% vs. 9.6%), and for the hydrocephalus requiring eventual permanent cerebrospinal fluid diversion (20.6% vs. 0%). Patients with d-SAH were also at an increased risk for symptomatic vasospasm (28.6% vs. 9.6%). Ultimately, only 76% of d-SAH patients achieved complete recovery and independent living, compared to 96.7% of p-SAH patients. The angiographically negative d-SAH pattern is associated with worse presentations and outcome. These patients are at increased risk for vasospasm and hydrocephalus requiring aggressive treatment and should therefore be cared for with a higher level of surveillance.
- Published
- 2009
44. Resolution of Oculomotor Nerve Palsy Secondary to Posterior Communicating Artery Aneurysms: Comparison between Clipping and Coiling
- Author
-
Gustavo Pradilla, C. Michael Cawley, Courtney McCracken, Brendan P. Lovasik, Raphael Tamargo, Daniel L. Barrow, and D Jay McCracken
- Subjects
medicine.medical_specialty ,business.industry ,medicine.artery ,medicine.medical_treatment ,medicine ,Neurology (clinical) ,Posterior communicating artery ,Anatomy ,Clipping (medicine) ,Oculomotor nerve palsy ,medicine.disease ,business ,Surgery - Published
- 2015
45. Surgical Endovascular Neuroradiology
- Author
-
Michelle J. Smith, Elia Haddad, Abhineet Chowdhary, Jacqueline A. Bello, Raul G. Nogueira, Guilherme Dabus, Pascal Jabbour, Issam A. Awad, Rebecca Ichord, B. Gregory Thompson, Babak S. Jahromi, Paritosh Pandey, Elad I. Levy, Maria G. Farrow, Lana D. Christiano, Robert D. Ecker, Peter K. Nelson, Erol Veznedaroglu, Reza J. Karimi, H. Hunt Batjer, Athos Patsalides, Bernard R. Bendok, Joan C. Wojak, Rocco Anthony Armonda, Demetrius K. Lopes, Augusto Elias, Neil V. Patel, Nakul Sheth, David M. Johnson, Robert W Tarr, Cormac O. Maher, Cameron G. McDougall, Randy S. Bell, Muhammad S Hussain, Gaurav Gupta, Theodore C. Larson, Ziad A. Hage, William L. Young, Michael C. Hurley, Keith E. Kortman, Gabriela Spilberg, Paula Klurfan, C. Michael Cawley, Aclan Dogan, Mahmoud Rayes, Andrew R. Xavier, Joshua A Hirsch, Andrew Kelly Johnson, Mary E. Jensen, Kevin M. Cockroft, L. Nelson Hopkins, Raqeeb M. Haque, Charles Kerber, Muhammad M. Abd-El-Barr, W. Christopher Fox, Daniel P Hsu, Dimitrios Giannakidis, Jacques E. Dion, Tomoki Hashimoto, Christopher Paul Kellner, David Altschul, David S. Lee, Kristine A Blackham, Ruchira M. Jha, Albert J. Yoo, David M. Mirsky, Ali Shaibani, Avi Mazumdar, Y. Jonathan Zhang, Martin D. Ollenschleger, Yince Loh, Aditya S. Pandey, Beverly Aagaard Kienitz, Gregory G. Heuer, Nazli Janjua, Louis P. Caragine, Joseph J. Gemmete, Michael J. Alexander, Felipe C. Albuquerque, Sunil Manjila, Celina Crisman, Jason Wilson, Anu Bansal, Yazan J. Alderazi, Vivek H. Tank, Kathleen McConnell, Aman B. Patel, E. Jesús Duffis, Ajay K. Wakhloo, Brian L. Hoh, Charles J. Prestigiacomo, Charles E. Romero, Michael F. Stiefel, Ravi Shah, Sean D. Lavine, Howard A. Riina, Daniel L. Surdell, Justin F. Fraser, Robert W. Hurst, Charles A. Guidot, Frank C. Tong, Gaurav Jain, Scott E. Olson, Christopher C. Getch, Chirag D. Gandhi, Michael Chen, Ferdinand K. Hui, Badih Daou, Tareq Kass-Hout, Colin P. Derdeyn, Karel G. terBrugge, Gary Duckwiler, Ryan L. Roberts, Daniel A. Nguyen, Koji Ebersole, Allan L. Brook, Andrew J. Ringer, Neeraj Chaudhary, Stanley L. Barnwell, Wayne Yakes, In Sup Choi, Ira M. Goldstein, Osamah J. Choudhry, Tibor Becske, Robert Alex Hirschl, Min S. Park, Philip Stieg, Roger E. Turbin, Christine Villegas, Philip M. Meyers, Vikas Gupta, Lei Feng, Phillip B. Storm, Jeffrey A. Stone, J D Mocco, Shah-Naz Hayat Khan, Y. Pierre Gobin, Scott A. Meyer, John B. Weigele, and Maksim Shapiro
- Subjects
medicine.medical_specialty ,business.industry ,medicine ,Radiology ,business ,Neuroradiology - Published
- 2015
46. Endovascular Therapy for Cavernous Sinus Vascular Lesions
- Author
-
C. Michael Cawley, Jacques E. Dion, Daniel L. Barrow, and Yi Jonathan Zhang
- Subjects
medicine.medical_specialty ,business.industry ,Cavernous sinus ,medicine ,Neurology (clinical) ,Radiology ,business ,Endovascular therapy - Published
- 2003
47. Evolution of the Management of Tentorial Dural Arteriovenous Malformations
- Author
-
L. Nelson Hopkins, Bernard R. Bendok, Robert H. Rosenwasser, Jacques E. Dion, Cameron G. McDougall, Duke Samson, Evandro de Oliveira, Robert F. Spetzler, Thomas A. Kopitnik, Harry J. Cloft, Felipe C. Albuquerque, Akihiko Kaga, César de Paula Lucas, C. Michael Cawley, Patrick R. Tomak, Daniel L. Barrow, and H. Hunt Batjer
- Subjects
Adult ,Male ,medicine.medical_specialty ,Dura mater ,Fistula ,medicine.medical_treatment ,Tentorium cerebelli ,Radiosurgery ,Veins ,Postoperative Complications ,medicine ,Humans ,Embolization ,Aged ,Retrospective Studies ,Aged, 80 and over ,Central Nervous System Vascular Malformations ,Neurologic Examination ,medicine.diagnostic_test ,business.industry ,Vascular disease ,Arteriovenous malformation ,Arteries ,Middle Aged ,medicine.disease ,Embolization, Therapeutic ,Cerebral Angiography ,Surgery ,Outcome and Process Assessment, Health Care ,medicine.anatomical_structure ,Angiography ,Female ,Dura Mater ,Neurology (clinical) ,Radiology ,Tomography, X-Ray Computed ,business ,Follow-Up Studies - Abstract
OBJECTIVE Tentorial dural arteriovenous malformations (DAVMs) are uncommon lesions associated with an aggressive natural history. Controversy exists regarding their optimal treatment. We present a single-institution series of tentorial DAVMs treated during a 12-year period, address the current controversies, and present the rationale for our current therapeutic strategy. METHODS Twenty-two patients with tentorial DAVMs were treated between 1988 and 2000. Treatment consisted of transarterial or transvenous embolization, surgical resection, disconnection of venous drainage, or a combination of these therapies. The clinical presentations, radiological features, treatment strategies, and results were studied. RESULTS Eighteen patients (82%) presented with intracranial hemorrhage or progressive neurological deficits. Retrograde leptomeningeal venous drainage was documented in 22 cases (100%), classifying the lesions as Borden Type III. Angiographic follow-up monitoring was performed for 0 to 120 months and clinical follow-up monitoring for 1 to 120 months. Posttreatment angiography demonstrated obliteration in 22 cases (100%). Two patients experienced neurological decline after endovascular treatment and died. All of the 20 surviving patients exhibited clinical improvement; there were no episodes of rehemorrhage or new neurological deficits. Outcomes were excellent in 17 cases (77%), good in 2 cases (9%), and fair in 1 case (5%), and there were 2 deaths (9%). CONCLUSION Tentorial DAVMs are aggressive lesions that require prompt total angiographic obliteration. Disconnection of the venous drainage from the fistula may be accomplished with transarterial embolization to the venous side, transvenous embolization, or surgical disconnection of the fistula. We think that extensive nidal resections carry more risk and are unnecessary. We do not think there is a role for stereotactic radiosurgery in the treatment of these lesions.
- Published
- 2003
48. Intraoperative angiography during aneurysm surgery: a prospective evaluation of efficacy
- Author
-
Daniel L. Barrow, Gordon Tang, Jacques E. Dion, and C. Michael Cawley
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Vascular disease ,medicine.medical_treatment ,Superior Hypophyseal Artery ,Clipping (medicine) ,medicine.disease ,Surgery ,Aneurysm ,medicine.artery ,Angiography ,cardiovascular system ,medicine ,Radiology ,Internal carotid artery ,Prospective cohort study ,business ,Cerebral angiography - Abstract
Object. Indications for intraoperative angiography during aneurysm surgery remain unclear. To define its use, the authors report the results of a prospective study in which this modality was used in all patients undergoing surgery for intracranial aneurysms. Methods. Intraoperative angiography was performed prospectively in the surgical treatment of 517 consecutive aneurysms regardless of the lesion's location, size, or complexity. In 64 (12.4%) of 517 aneurysms intraoperative angiography findings prompted a change in surgical treatment. Residual aneurysm (47%) was the most frequent finding leading to clip revision. In 44% of cases, intraoperative angiography revealed vessel compromise. Surgery for aneurysms of the proximal internal carotid artery (ICA) was the most frequently altered, with lesions located at the superior hypophyseal artery (SHA) and clinoidal region having the highest revision rates, eight (40%) of 20 and eight (44%) of 18, respectively. Aneurysm size predicted the need for revision; giant aneurysms (> 24 mm) underwent revision in nine (29%) of 31 cases, whereas large aneurysms (15–24 mm) were revised in 12 (22%) of 54 cases. In a multivariate logistic regression model, factors related to increased revision rates included the SHA and clinoidal locations, as well as giant and large size. Ninety-five patients underwent both intraoperative and postoperative angiography. Five discrepancies were noted (95% accuracy); four were flow-related and one involved a previously unrecognized residual aneurysm. Complications attributable to intraoperative angiography occurred in 0.4% of cases. Conclusions. Proximal ICA location and large aneurysm size significantly predicted revision of surgery following intraoperative angiography. Unexpected findings, even in less complex locations, are frequently identified on intraoperative angiography. Low complication rates, high accuracy, and the unexpected need for clip readjustments favor a more widespread use of intraoperative angiography.
- Published
- 2002
49. Effect of antiplatelet therapy and platelet function testing on hemorrhagic and thrombotic complications in patients with cerebral aneurysms treated with the pipeline embolization device: a review and meta-analysis
- Author
-
Susana L Skukalek, C. Michael Cawley, Mark J Dannenbaum, Bill Asbury, Anne M. Winkler, Jian Kang, Albert J Schuette, Frank C. Tong, Jacques E. Dion, and Adam Webb
- Subjects
Platelet Function Tests ,medicine.medical_treatment ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Aneurysm ,Thromboembolism ,Medicine ,Humans ,Platelet ,Embolization ,Cerebral Hemorrhage ,Aspirin ,business.industry ,Incidence (epidemiology) ,Intracranial Aneurysm ,General Medicine ,Clopidogrel ,medicine.disease ,Embolization, Therapeutic ,Anesthesia ,Meta-analysis ,Surgery ,Neurology (clinical) ,business ,Complication ,030217 neurology & neurosurgery ,Platelet Aggregation Inhibitors ,medicine.drug - Abstract
PurposeThe pipeline embolization device (PED) necessitates dual antiplatelet therapy (APT) to decrease thrombotic complications while possibly increasing bleeding risks. The role of APT dose, duration, and response in patients with hemorrhagic and thromboembolic events warrants further analysis.MethodsA PubMed and Google Scholar search from 2009 to 2014 was performed using the following search terms individually or in combination: pipeline embolization device, aneurysm(s), and flow diversion, excluding other flow diverters. Review of the bibliographies of the retrieved articles yielded 19 single and multicenter studies. A statistical meta-analysis between aspirin (ASA) dose (low dose ≤160 mg, high dose ≥300 mg), loading doses of APT agents, post-PED APT regimens, and platelet function testing (PFT) with hemorrhagic or thrombotic complications was performed.ResultsASA therapy for ≤6 months post-PED was associated with increased hemorrhagic events. High dose ASA ≤6 months post-PED was associated with fewer thrombotic events compared with low dose ASA. Post-PED clopidogrel for ≤6 months demonstrated an increased incidence of symptomatic thrombotic events. Loading doses of ASA plus clopidogrel demonstrated a decreased incidence of permanent symptomatic hemorrhagic events. PFT did not show a statistically significant relationship with symptomatic hemorrhagic or thrombotic complications.ConclusionsHigh dose ASA >6 months is associated with fewer permanent thrombotic and hemorrhagic events. Clopidogrel therapy ≤6 months is associated with higher rates of thrombotic events. Loading doses of ASA and clopidogrel were associated with a decreased incidence of hemorrhagic events. PFT did not have any significant association with symptomatic events.
- Published
- 2014
50. Advances in surgical approaches to dural fistulas
- Author
-
C. Michael Cawley, Daniel L. Barrow, Albert Jess Schuette, and Patrick P. Youssef
- Subjects
musculoskeletal diseases ,congenital, hereditary, and neonatal diseases and abnormalities ,medicine.medical_specialty ,Fistula ,medicine.medical_treatment ,Arteriovenous fistula ,Radiosurgery ,Veins ,Dural arteriovenous fistulas ,otorhinolaryngologic diseases ,Medicine ,Humans ,Embolization ,Sinus (anatomy) ,Central Nervous System Vascular Malformations ,business.industry ,medicine.disease ,Embolization, Therapeutic ,nervous system diseases ,Surgery ,Cerebral Angiography ,Skull ,medicine.anatomical_structure ,Dural venous sinuses ,Neurology (clinical) ,Dura Mater ,business - Abstract
Dural arteriovenous fistulas are abnormal connections of dural arteries to dural veins or venous sinuses originating from within the dural leaflets. They are usually located near or within the wall of a dural venous sinus that is frequently obstructed or stenosed. The dural fistula sac is contained within the dural leaflets, and drainage can be via a dural sinus or retrograde through cortical veins (leptomeningeal drainage). Dural arteriovenous fistulas can occur at any dural sinus but are found most frequently at the cavernous or transverse sinus. Leptomeningeal venous drainage can lead to venous hypertension and intracranial hemorrhage. The various treatment options include transarterial and transvenous embolization, stereotactic radiosurgery, and open surgery. Although many of the advances in dural arteriovenous fistula treatment have occurred in the endovascular arena, open microsurgical advances in the past decade have primarily been in the tools available to the surgeon. Improvements in microsurgical and skull base approaches have allowed surgeons to approach and obliterate fistulas with little or no retraction of the brain. Image-guided systems have also allowed better localization and more efficient approaches. A better understanding of the need to simply obliterate the venous drainage at the site of the fistula has eliminated the riskier resections of the past. Finally, the use of intraoperative angiography or indocyanine green videoangiography confirms the complete disconnection of fistula while the patient is still on the operating room table, preventing reoperation for residual fistulas.
- Published
- 2014
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.